| (+)-pilocarpine | increases activity | EXP | | 6480464 | Pilocarpine results in increased activity of MMP9 protein | CTD | PMID:19631748 |
| (+)-pilocarpine | increases expression | EXP | | 6480464 | Pilocarpine results in increased expression of MMP9 protein | CTD | PMID:19631748 |
| (-)-epigallocatechin 3-gallate | multiple interactions | EXP | | 6480464 | epigallocatechin gallate inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:16516891 |
| (-)-epigallocatechin 3-gallate | decreases activity | EXP | | 6480464 | epigallocatechin gallate results in decreased activity of MMP9 protein | CTD | PMID:11746506 |
| (R)-mevalonic acid | multiple interactions | ISO | RGD:1348437 | 6480464 | Mevalonic Acid inhibits the reaction [Simvastatin inhibits the reaction [[IL1A co-treated with PDGFB] results in increased secretion of MMP9 protein]]; more ... | CTD | PMID:15728660 |
| (R)-noradrenaline | multiple interactions | ISO | RGD:621320 | 6480464 | crocetin inhibits the reaction [Norepinephrine results in increased expression of MMP9 mRNA] | CTD | PMID:16864425 |
| (R)-noradrenaline | increases expression | ISO | RGD:621320 | 6480464 | Norepinephrine results in increased expression of MMP9 mRNA | CTD | PMID:16864425 |
| (R)-noradrenaline | increases activity | ISO | RGD:621320 | 6480464 | Norepinephrine results in increased activity of MMP9 protein | CTD | PMID:16864425 |
| (S)-nicotine | increases expression | ISO | RGD:1348437 | 6480464 | Nicotine results in increased expression of MMP9 mRNA | CTD | PMID:20061081 |
| (S)-nicotine | decreases expression | EXP | | 6480464 | Nicotine results in decreased expression of MMP9 protein | CTD | PMID:20448088 |
| (S)-nicotine | increases expression | ISO | RGD:1348437 | 6480464 | Nicotine results in increased expression of MMP9 protein | CTD | PMID:14569062 |
| (S)-nicotine | multiple interactions | ISO | RGD:1348437 | 6480464 | L 663536 inhibits the reaction [Nicotine results in increased expression of MMP9 mRNA] | CTD | PMID:20061081 |
| 1'-acetoxychavicol acetate | multiple interactions | ISO | RGD:1348437 | 6480464 | 1'-acetoxychavicol acetate inhibits the reaction [TNF protein results in increased expression of MMP9 protein] | CTD | PMID:15905586 |
| 1,1-bis(2-aminoethyl)-2-hydroxy-3-oxotriazane | multiple interactions | ISO | RGD:621320 | 6480464 | 2,2'-(hydroxynitrosohydrazono)bis-ethanamine inhibits the reaction [IL1B protein results in increased activity of MMP9 protein]; more ... | CTD | PMID:16378139 |
| 1,10-phenanthroline | multiple interactions | EXP | | 6480464 | 1,10-phenanthroline inhibits the reaction [PLAU protein results in increased activity of MMP9 protein] | CTD | PMID:20177776 |
| 1,10-phenanthroline | multiple interactions | ISO | RGD:621320 | 6480464 | 1,10-phenanthroline inhibits the reaction [Adenosine Triphosphate results in increased activity of MMP9 protein] | CTD | PMID:20195827 |
| 1,3-benzothiazole-2-thiol | increases expression | ISO | RGD:1348437 | 6480464 | captax results in increased expression of MMP9 protein; more ... | CTD | PMID:22952646 |
| 17alpha-ethynylestradiol | decreases expression | EXP | | 6480464 | Ethinyl Estradiol results in decreased expression of MMP9 protein | CTD | PMID:12538720 |
| 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of MMP9 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MMP9 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | affects expression | EXP | | 6480464 | Ethinyl Estradiol affects the expression of MMP9 mRNA | CTD | PMID:17555576 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1348437 | 6480464 | [Progesterone co-treated with Estradiol] results in decreased expression of MMP9 mRNA | CTD | PMID:17404688 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1348437 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Estradiol results in decreased expression of MMP9 mRNA]; more ... | CTD | PMID:19956873 |
| 17beta-estradiol | decreases expression | ISO | RGD:1348437 | 6480464 | Estradiol results in decreased expression of MMP9 protein; more ... | CTD | PMID:19956873 |
| 17beta-estradiol | increases secretion | ISO | RGD:1348437 | 6480464 | Estradiol results in increased secretion of MMP9 protein | CTD | PMID:20951759 |
| 17beta-estradiol | increases expression | ISO | RGD:1348437 | 6480464 | Estradiol results in increased expression of MMP9 protein | CTD | PMID:12948864 |
| 17beta-estradiol | increases activity | EXP | | 6480464 | Estradiol results in increased activity of MMP9 protein | CTD | PMID:19279558 |
| 2,2'-bipyridine | increases activity | ISO | RGD:1348437 | 6480464 | 2,2'-Dipyridyl results in increased activity of MMP9 protein | CTD | PMID:18674879 |
| 2,2'-bipyridine | multiple interactions | ISO | RGD:1348437 | 6480464 | resveratrol inhibits the reaction [2,2'-Dipyridyl results in increased activity of MMP9 protein] | CTD | PMID:18674879 |
| 2,2'-bipyridine | increases expression | ISO | RGD:1348437 | 6480464 | 2,2'-Dipyridyl results in increased expression of MMP9 mRNA | CTD | PMID:18674879 |
| 2,2,2-trichloroethanol | increases activity | ISO | RGD:1348437 | 6480464 | 2,2,2-trichloroethanol results in increased activity of MMP9 protein | CTD | PMID:21741468 |
| 2,2,2-trichloroethanol | increases expression | ISO | RGD:1348437 | 6480464 | 2,2,2-trichloroethanol results in increased expression of MMP9 mRNA; more ... | CTD | PMID:21741468 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1348437 | 6480464 | JUN protein affects the reaction [Tetrachlorodibenzodioxin results in increased activity of MMP9 protein]; more ... | CTD | PMID:19371443 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | tributyltin promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of MMP9 mRNA] | CTD | PMID:22749964 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MMP9 mRNA | CTD | PMID:17586704 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of MMP9 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MMP9 mRNA | CTD | PMID:17586704 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1348437 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MMP9 mRNA | CTD | PMID:12377990 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MMP9 mRNA | CTD | PMID:17586704 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1348437 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MMP9 mRNA | CTD | PMID:12377990 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1348437 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MMP9 mRNA | CTD | PMID:19755661 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases activity | ISO | RGD:1348437 | 6480464 | Tetrachlorodibenzodioxin results in increased activity of MMP9 protein | CTD | PMID:19371443 PMID:15922868 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MMP9 mRNA | CTD | PMID:19372248 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1348437 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MMP9 mRNA | CTD | PMID:16704738 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1348437 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MMP9 mRNA | CTD | PMID:16704738 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MMP9 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MMP9 mRNA | CTD | PMID:19372248 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1348437 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MMP9 mRNA | CTD | PMID:19371443 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in decreased expression of MMP9 mRNA | CTD | PMID:21167638 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1348437 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MMP9 | CTD | PMID:17003102 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1348437 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of MMP9 protein | CTD | PMID:15982688 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases activity | ISO | RGD:1348437 | 6480464 | Tetrachlorodibenzodioxin results in increased activity of MMP9 protein | CTD | PMID:15922868 PMID:19371443 |
| 2,4,6-trinitrobenzenesulfonic acid | multiple interactions | ISO | RGD:621320 | 6480464 | 4-methylesculetin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of and results in increased cleavage of MMP9 protein]; more ... | CTD | PMID:22119283 |
| 2-acetamidofluorene | increases expression | ISO | RGD:621320 | 6480464 | 2-Acetylaminofluorene results in increased expression of MMP9 mRNA | CTD | PMID:18678246 |
| 2-amino-2-deoxy-D-glucopyranose | multiple interactions | ISO | RGD:1348437 | 6480464 | Glucosamine analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]; more ... | CTD | PMID:19375915 |
| 2-amino-2-deoxy-D-glucopyranose | increases expression | ISO | RGD:621320 | 6480464 | Glucosamine results in increased expression of MMP9 mRNA | CTD | PMID:17109745 |
| 2-amino-2-deoxy-D-glucopyranose | multiple interactions | ISO | RGD:621320 | 6480464 | Glucosamine inhibits the reaction [IL1B results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:17109745 |
| 2-amino-2-deoxy-D-glucopyranose | multiple interactions | ISO | RGD:1348437 | 6480464 | Glucosamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:17498959 |
| 2-trans,6-trans,10-trans-geranylgeranyl diphosphate | multiple interactions | ISO | RGD:1348437 | 6480464 | geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [[IL1A co-treated with PDGFB] results in increased expression of MMP9 mRNA]]; more ... | CTD | PMID:15728660 |
| 2-trans,6-trans,10-trans-geranylgeranyl diphosphate | multiple interactions | ISO | RGD:621320 | 6480464 | geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Smoke analog results in increased expression of MMP9]]; more ... | CTD | PMID:19299917 |
| 2-trans,6-trans-farnesyl diphosphate | multiple interactions | ISO | RGD:621320 | 6480464 | farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Smoke analog results in increased expression of MMP9 mRNA]]; more ... | CTD | PMID:19299917 |
| 3,3',4,4',5-pentachlorobiphenyl | affects expression | ISO | RGD:1348437 | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl affects the expression of MMP9 mRNA | CTD | PMID:21703328 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | decreases expression | EXP | | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of MMP9 mRNA | CTD | PMID:21167638 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in decreased expression of MMP9 mRNA | CTD | PMID:21167638 |
| 4-hydroxynon-2-enal | increases expression | EXP | | 6480464 | 4-hydroxy-2-nonenal results in increased expression of MMP9 protein; more ... | CTD | PMID:19191707 |
| 4-hydroxynon-2-enal | increases activity | EXP | | 6480464 | 4-hydroxy-2-nonenal results in increased activity of MMP9 protein | CTD | PMID:19837106 |
| 4-hydroxynon-2-enal | multiple interactions | EXP | | 6480464 | ALOX5 mutant form inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of MMP9 protein]; more ... | CTD | PMID:19837106 |
| 4-hydroxynon-2-enal | increases expression | EXP | | 6480464 | 4-hydroxy-2-nonenal results in increased expression of MMP9 protein | CTD | PMID:19191707 PMID:19837106 |
| 4-hydroxynon-2-enal | decreases expression | EXP | | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of MMP9 mRNA | CTD | PMID:19191707 |
| 4-hydroxyphenyl retinamide | multiple interactions | ISO | RGD:1348437 | 6480464 | Fenretinide inhibits the reaction [TNF protein results in increased expression of MMP9 protein] | CTD | PMID:16230421 |
| 4-nitroquinoline N-oxide | increases expression | EXP | | 6480464 | 4-Nitroquinoline-1-oxide results in increased expression of MMP9 mRNA | CTD | PMID:22561872 |
| 5,6alpha-epoxy-5alpha-cholestan-3beta-ol | increases expression | ISO | RGD:621320 | 6480464 | cholesterol alpha-oxide results in increased expression of MMP9 mRNA | CTD | PMID:20466046 |
| 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide | decreases activity | ISO | RGD:1348437 | 6480464 | AICA ribonucleotide results in decreased activity of MMP9 protein | CTD | PMID:20590612 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:1348437 | 6480464 | decitabine inhibits the reaction [sodium arsenite results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:21167264 |
| 5-azacytidine | multiple interactions | ISO | RGD:1348437 | 6480464 | metacept-1 inhibits the reaction [Azacitidine results in increased expression of MMP9] | CTD | PMID:19148494 |
| 5-fluorouracil | affects expression | ISO | RGD:1348437 | 6480464 | Fluorouracil affects the expression of MMP9 mRNA | CTD | PMID:15205334 |
| 7,12-dimethyltetraphene | increases expression | ISO | RGD:621320 | 6480464 | 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MMP9 protein | CTD | PMID:12208745 |
| 7,12-dimethyltetraphene | affects expression | EXP | | 6480464 | 9,10-Dimethyl-1,2-benzanthracene affects the expression of MMP9 mRNA | CTD | PMID:21785161 |
| 7,12-dimethyltetraphene | multiple interactions | ISO | RGD:621320 | 6480464 | resveratrol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MMP9 protein] | CTD | PMID:12208745 |
| 7-ketocholesterol | increases expression | ISO | RGD:621320 | 6480464 | 7-ketocholesterol results in increased expression of MMP9 mRNA | CTD | PMID:20466046 |
| acetaldehyde | multiple interactions | ISO | RGD:1348437 | 6480464 | Acetaldehyde results in increased expression of and results in increased activity of MMP9 protein; more ... | CTD | PMID:19110045 |
| acetaldehyde | increases expression | ISO | RGD:1348437 | 6480464 | Acetaldehyde results in increased expression of MMP9 mRNA | CTD | PMID:19110045 |
| acetylcholine | affects response to substance | EXP | | 6480464 | MMP9 protein affects the susceptibility to Acetylcholine | CTD | PMID:16979597 |
| acetylsalicylic acid | decreases expression | ISO | RGD:1348437 | 6480464 | Aspirin results in decreased expression of MMP9 mRNA | CTD | PMID:19880272 more ... |
| acetylsalicylic acid | decreases expression | ISO | RGD:1348437 | 6480464 | Aspirin results in decreased expression of MMP9 mRNA | CTD | PMID:15928584 more ... |
| acetylsalicylic acid | decreases expression | ISO | RGD:1348437 | 6480464 | Aspirin results in decreased expression of MMP9 mRNA | CTD | PMID:20137092 more ... |
| acetylsalicylic acid | decreases secretion | ISO | RGD:1348437 | 6480464 | Aspirin results in decreased secretion of MMP9 protein | CTD | PMID:18971601 PMID:19880272 |
| acetylsalicylic acid | decreases secretion | EXP | | 6480464 | Aspirin results in decreased secretion of MMP9 protein | CTD | PMID:19462226 |
| acetylsalicylic acid | decreases expression | EXP | | 6480464 | Aspirin results in decreased expression of MMP9 mRNA | CTD | PMID:19462226 |
| acetylsalicylic acid | decreases secretion | ISO | RGD:1348437 | 6480464 | Aspirin results in decreased secretion of MMP9 protein | CTD | PMID:19880272 PMID:18971601 |
| acetylsalicylic acid | decreases expression | ISO | RGD:1348437 | 6480464 | Aspirin results in decreased expression of MMP9 mRNA | CTD | PMID:20137092 more ... |
| acetylsalicylic acid | decreases expression | ISO | RGD:1348437 | 6480464 | Aspirin results in decreased expression of MMP9 | CTD | PMID:18971601 |
| acetylsalicylic acid | decreases activity | ISO | RGD:1348437 | 6480464 | Aspirin results in decreased activity of MMP9 protein | CTD | PMID:20137092 |
| acetylsalicylic acid | multiple interactions | ISO | RGD:1348437 | 6480464 | Aspirin inhibits the reaction [HGF results in increased expression of MMP9] | CTD | PMID:11981761 |
| acetylsalicylic acid | decreases expression | ISO | RGD:1348437 | 6480464 | Aspirin results in decreased expression of MMP9 mRNA | CTD | PMID:15928584 |
| acrolein | multiple interactions | ISO | RGD:1348437 | 6480464 | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Acrolein results in increased expression of MMP9 protein]; more ... | CTD | PMID:19371603 |
| acrolein | multiple interactions | EXP | | 6480464 | Acrolein results in increased expression of and results in increased activity of MMP9 protein | CTD | PMID:20153347 |
| acrolein | increases activity | EXP | | 6480464 | Acrolein results in increased activity of MMP9 protein | CTD | PMID:18006877 PMID:17950725 |
| acrolein | increases expression | ISO | RGD:1348437 | 6480464 | Acrolein results in increased expression of MMP9 mRNA | CTD | PMID:15531749 PMID:18006877 |
| acrolein | increases activity | ISO | RGD:1348437 | 6480464 | Acrolein results in increased activity of MMP9 protein | CTD | PMID:15531749 PMID:18006877 |
| acrolein | multiple interactions | EXP | | 6480464 | MMP9 gene mutant form inhibits the reaction [Acrolein results in increased expression of MUC5AC mRNA] | CTD | PMID:18006877 |
| acrolein | multiple interactions | EXP | | 6480464 | CD8A gene mutant form inhibits the reaction [Acrolein results in increased activity of MMP9 protein] | CTD | PMID:17950725 |
| acrolein | increases expression | EXP | | 6480464 | Acrolein results in increased expression of MMP9 protein; more ... | CTD | PMID:18006877 |
| acrolein | increases activity | EXP | | 6480464 | Acrolein results in increased activity of MMP9 protein | CTD | PMID:17950725 PMID:18006877 |
| acrolein | multiple interactions | ISO | RGD:1348437 | 6480464 | GM 6001 inhibits the reaction [Acrolein results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:18006877 |
| acrolein | multiple interactions | ISO | RGD:1348437 | 6480464 | MMP9 protein promotes the reaction [Acrolein results in increased expression of MUC5AC mRNA] | CTD | PMID:15531749 |
| acrolein | increases secretion | ISO | RGD:1348437 | 6480464 | Acrolein results in increased secretion of MMP9 protein | CTD | PMID:15531749 |
| acrolein | increases expression | ISO | RGD:1348437 | 6480464 | Acrolein results in increased expression of MMP9 mRNA | CTD | PMID:18006877 PMID:15531749 |
| acrolein | increases expression | ISO | RGD:1348437 | 6480464 | Acrolein results in increased expression of MMP9 protein | CTD | PMID:15531749 |
| acrolein | increases activity | ISO | RGD:1348437 | 6480464 | Acrolein results in increased activity of MMP9 protein | CTD | PMID:18006877 PMID:15531749 |
| acrolein | increases cleavage | ISO | RGD:1348437 | 6480464 | Acrolein results in increased cleavage of MMP9 protein | CTD | PMID:18006877 |
| alachlor | increases expression | ISO | RGD:621320 | 6480464 | alachlor results in increased expression of MMP9 mRNA | CTD | PMID:12419858 |
| aldehydo-D-glucosamine | multiple interactions | ISO | RGD:1348437 | 6480464 | Glucosamine analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]; more ... | CTD | PMID:19375915 |
| aldehydo-D-glucosamine | increases expression | ISO | RGD:621320 | 6480464 | Glucosamine results in increased expression of MMP9 mRNA | CTD | PMID:17109745 |
| aldehydo-D-glucosamine | multiple interactions | ISO | RGD:621320 | 6480464 | Glucosamine inhibits the reaction [IL1B results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:17109745 |
| aldehydo-D-glucosamine | multiple interactions | ISO | RGD:1348437 | 6480464 | Glucosamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:17498959 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:1348437 | 6480464 | Tretinoin results in decreased expression of and results in decreased secretion of MMP9 protein | CTD | PMID:16914095 |
| all-trans-retinoic acid | increases expression | ISO | RGD:621320 | 6480464 | Tretinoin results in increased expression of MMP9 mRNA | CTD | PMID:20488242 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:621320 | 6480464 | Tretinoin inhibits the reaction [Doxorubicin results in decreased expression of MMP9 protein]; more ... | CTD | PMID:19357873 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of MMP9 mRNA | CTD | PMID:16788091 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:1348437 | 6480464 | Tretinoin results in decreased expression of MMP9 mRNA | CTD | PMID:16914095 |
| all-trans-retinyl palmitate | multiple interactions | ISO | RGD:621320 | 6480464 | retinol palmitate promotes the reaction [EP300 protein binds to MMP9 protein]; more ... | CTD | PMID:17164434 |
| all-trans-retinyl palmitate | increases expression | ISO | RGD:621320 | 6480464 | retinol palmitate results in increased expression of MMP9 mRNA | CTD | PMID:17164434 |
| allopurinol | multiple interactions | ISO | RGD:1348437 | 6480464 | Allopurinol inhibits the reaction [Acrolein results in increased expression of MMP9 protein] | CTD | PMID:19371603 |
| alloxanthine | multiple interactions | ISO | RGD:1348437 | 6480464 | Oxypurinol inhibits the reaction [Acrolein results in increased expression of MMP9 protein] | CTD | PMID:19371603 |
| aluminium atom | increases expression | ISO | RGD:621320 | 6480464 | Aluminum results in increased expression of MMP9 protein | CTD | PMID:16052892 |
| aluminium oxide | increases expression | ISO | RGD:1348437 | 6480464 | Aluminum Oxide results in increased expression of MMP9 mRNA | CTD | PMID:16488289 |
| aluminium(0) | increases expression | ISO | RGD:621320 | 6480464 | Aluminum results in increased expression of MMP9 protein | CTD | PMID:16052892 |
| aminoguanidine | multiple interactions | ISO | RGD:621320 | 6480464 | pimagedine inhibits the reaction [Isoproterenol results in increased expression of MMP9 mRNA] | CTD | PMID:18594475 |
| aminoguanidine | multiple interactions | EXP | | 6480464 | pimagedine inhibits the reaction [Glucose results in increased activity of MMP9 protein]; more ... | CTD | PMID:22543014 |
| ammonium chloride | affects expression | ISO | RGD:621320 | 6480464 | Ammonium Chloride affects the expression of MMP9 mRNA | CTD | PMID:16483693 |
| anandamide | multiple interactions | ISO | RGD:1348437 | 6480464 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [anandamide results in increased expression of MMP9 mRNA] | CTD | PMID:16330497 |
| anandamide | increases expression | ISO | RGD:1348437 | 6480464 | anandamide results in increased expression of MMP9 mRNA | CTD | PMID:16330497 |
| apigenin | multiple interactions | ISO | RGD:1348437 | 6480464 | Apigenin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]; more ... | CTD | PMID:22634262 |
| arachidonic acid | increases expression | ISO | RGD:1348437 | 6480464 | Arachidonic Acid results in increased expression of MMP9 mRNA | CTD | PMID:16185265 |
| arachidonic acid | multiple interactions | ISO | RGD:1348437 | 6480464 | Isotretinoin inhibits the reaction [Arachidonic Acid results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:16185265 |
| arachidonic acid | increases secretion | ISO | RGD:1348437 | 6480464 | Arachidonic Acid results in increased secretion of MMP9 protein | CTD | PMID:16185265 |
| arsenic atom | increases expression | EXP | | 6480464 | Arsenic results in increased expression of MMP9 mRNA | CTD | PMID:19654921 |
| arsenic atom | multiple interactions | ISO | RGD:1348437 | 6480464 | Arsenic results in increased expression of and results in increased activity of MMP9 protein | CTD | PMID:18539681 |
| arsenite(3-) | increases expression | ISO | RGD:1348437 | 6480464 | arsenite results in increased expression of MMP9 mRNA | CTD | PMID:18296743 |
| arsenite(3-) | increases secretion | ISO | RGD:1348437 | 6480464 | arsenite results in increased secretion of MMP9 protein | CTD | PMID:22011395 |
| arsenite(3-) | decreases expression | EXP | | 6480464 | arsenite results in decreased expression of MMP9 mRNA | CTD | PMID:18929588 |
| arsenite(3-) | multiple interactions | EXP | | 6480464 | TRP53 protein affects the reaction [arsenite results in decreased expression of MMP9 mRNA] | CTD | PMID:18929588 |
| arsenite(3-) | affects expression | EXP | | 6480464 | arsenite affects the expression of MMP9 mRNA | CTD | PMID:15738583 |
| arsenite(3-) | multiple interactions | ISO | RGD:1348437 | 6480464 | Dietary Fats promotes the reaction [arsenite results in increased expression of MMP9 mRNA] | CTD | PMID:18296743 |
| arsenite(3-) | increases expression | ISO | RGD:1348437 | 6480464 | arsenite results in increased expression of MMP9 protein | CTD | PMID:12488483 |
| ATP | multiple interactions | ISO | RGD:621320 | 6480464 | GM 6001 inhibits the reaction [Adenosine Triphosphate results in increased activity of MMP9 protein]; more ... | CTD | PMID:20195827 |
| ATP | increases secretion | ISO | RGD:621320 | 6480464 | Adenosine Triphosphate results in increased secretion of MMP9 protein | CTD | PMID:20195827 |
| ATP | increases activity | ISO | RGD:621320 | 6480464 | Adenosine Triphosphate results in increased activity of MMP9 protein | CTD | PMID:20195827 |
| baicalein | multiple interactions | ISO | RGD:1348437 | 6480464 | baicalein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] | CTD | PMID:19804834 |
| baicalein | multiple interactions | EXP | | 6480464 | baicalein inhibits the reaction [Benzo(a)pyrene results in increased expression of MMP9 mRNA] | CTD | PMID:22369883 |
| baicalein | decreases activity | ISO | RGD:1348437 | 6480464 | baicalein results in decreased activity of MMP9 protein | CTD | PMID:21803068 |
| BAPTA | multiple interactions | ISO | RGD:1348437 | 6480464 | 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Acrolein results in increased expression of MMP9 protein] | CTD | PMID:19371603 |
| benazepril | increases activity | EXP | | 6480464 | benazepril results in increased activity of MMP9 protein | CTD | PMID:15339989 |
| benazepril | decreases expression | ISO | RGD:1348437 | 6480464 | benazepril results in decreased expression of MMP9 protein | CTD | PMID:20981132 |
| benazepril | multiple interactions | ISO | RGD:621320 | 6480464 | benazepril inhibits the reaction [Doxorubicin results in decreased expression of MMP9 mRNA]; more ... | CTD | PMID:19357873 |
| benomyl | decreases expression | ISO | RGD:621320 | 6480464 | Benomyl results in decreased expression of MMP9 protein | CTD | PMID:10026946 |
| benzene | increases expression | ISO | RGD:1348437 | 6480464 | Benzene results in increased expression of MMP9 mRNA | CTD | PMID:19162166 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1348437 | 6480464 | Benzo(a)pyrene results in decreased expression of MMP9 mRNA | CTD | PMID:20106945 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | baicalein inhibits the reaction [Benzo(a)pyrene results in increased expression of MMP9 mRNA] | CTD | PMID:22369883 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of MMP9 mRNA | CTD | PMID:22369883 |
| benzo[a]pyrene | increases expression | ISO | RGD:621320 | 6480464 | Benzo(a)pyrene results in increased expression of MMP9 protein | CTD | PMID:21467743 |
| benzo[a]pyrene | affects expression | EXP | | 6480464 | Benzo(a)pyrene affects the expression of MMP9 mRNA | CTD | PMID:22342234 |
| benzo[a]pyrene | increases expression | ISO | RGD:621320 | 6480464 | Benzo(a)pyrene results in increased expression of MMP9 mRNA | CTD | PMID:19022365 |
| benzo[a]pyrene | increases activity | ISO | RGD:1348437 | 6480464 | Benzo(a)pyrene results in increased activity of MMP9 protein | CTD | PMID:15922868 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:621320 | 6480464 | alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of MMP9 mRNA] | CTD | PMID:19022365 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of MMP9 mRNA | CTD | PMID:20713471 |
| benzo[a]pyrene | increases expression | ISO | RGD:1348437 | 6480464 | Benzo(a)pyrene results in increased expression of MMP9 mRNA | CTD | PMID:15922868 |
| benzyl acetate | increases expression | ISO | RGD:1348437 | 6480464 | benzyl acetate results in increased expression of MMP9 mRNA; more ... | CTD | PMID:22952646 |
| beta-D-glucosamine | multiple interactions | ISO | RGD:1348437 | 6480464 | Glucosamine analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]; more ... | CTD | PMID:19375915 |
| beta-D-glucosamine | increases expression | ISO | RGD:621320 | 6480464 | Glucosamine results in increased expression of MMP9 mRNA | CTD | PMID:17109745 |
| beta-D-glucosamine | multiple interactions | ISO | RGD:621320 | 6480464 | Glucosamine inhibits the reaction [IL1B results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:17109745 |
| beta-D-glucosamine | multiple interactions | ISO | RGD:1348437 | 6480464 | Glucosamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:17498959 |
| beta-hexachlorocyclohexane | increases expression | ISO | RGD:1348437 | 6480464 | beta-hexachlorocyclohexane results in increased expression of MMP9 protein | CTD | PMID:12948864 |
| biochanin A | decreases activity | ISO | RGD:1348437 | 6480464 | biochanin A results in decreased activity of MMP9 protein | CTD | PMID:16598420 |
| bis(2-chloroethyl) sulfide | increases expression | EXP | | 6480464 | Mustard Gas results in increased expression of MMP9 mRNA | CTD | PMID:18955075 PMID:16489579 |
| bis(2-chloroethyl) sulfide | increases expression | ISO | RGD:621320 | 6480464 | Mustard Gas results in increased expression of MMP9 protein | CTD | PMID:20659490 |
| bis(2-chloroethyl) sulfide | increases secretion | ISO | RGD:1348437 | 6480464 | Mustard Gas results in increased secretion of MMP9 protein | CTD | PMID:18809459 |
| bis(2-chloroethyl) sulfide | increases expression | ISO | RGD:1348437 | 6480464 | Mustard Gas results in increased expression of MMP9 mRNA | CTD | PMID:18809459 |
| bis(2-chloroethyl) sulfide | increases expression | EXP | | 6480464 | Mustard Gas results in increased expression of MMP9 mRNA | CTD | PMID:16489579 PMID:18955075 |
| bis(2-chloroethyl) sulfide | increases expression | EXP | | 6480464 | Mustard Gas results in increased expression of MMP9 protein | CTD | PMID:16489579 |
| bis(2-ethylhexyl) phthalate | increases expression | ISO | RGD:621320 | 6480464 | Diethylhexyl Phthalate results in increased expression of MMP9 mRNA | CTD | PMID:20920545 |
| bis(2-ethylhexyl) phthalate | increases expression | ISO | RGD:1348437 | 6480464 | Diethylhexyl Phthalate results in increased expression of MMP9 mRNA; more ... | CTD | PMID:19956873 |
| bis(2-ethylhexyl) phthalate | multiple interactions | ISO | RGD:1348437 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Diethylhexyl Phthalate results in increased expression of MMP9 protein]; more ... | CTD | PMID:19956873 |
| bisdemethoxycurcumin | multiple interactions | ISO | RGD:1348437 | 6480464 | bis(4-hydroxycinnamoyl)methane results in decreased secretion of and results in decreased activity of MMP9 protein | CTD | PMID:18495463 |
| bisphenol A | multiple interactions | ISO | RGD:1348437 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [bisphenol A results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:19956873 |
| bisphenol A | increases expression | ISO | RGD:1348437 | 6480464 | bisphenol A results in increased expression of MMP9 mRNA; more ... | CTD | PMID:19956873 |
| budesonide | multiple interactions | ISO | RGD:621320 | 6480464 | Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of MMP9 mRNA] | CTD | PMID:15734790 |
| bufalin | decreases activity | ISO | RGD:1348437 | 6480464 | bufalin results in decreased activity of MMP9 protein | CTD | PMID:21922632 |
| butein | decreases expression | ISO | RGD:1348437 | 6480464 | butein results in decreased expression of MMP9 protein; more ... | CTD | PMID:20696233 |
| butein | multiple interactions | ISO | RGD:1348437 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [butein results in decreased expression of MMP9 protein]; more ... | CTD | PMID:20696233 |
| cadmium atom | increases secretion | ISO | RGD:1348437 | 6480464 | Cadmium results in increased secretion of MMP9 mRNA | CTD | PMID:20049202 |
| cadmium atom | increases secretion | ISO | RGD:1348437 | 6480464 | Cadmium results in increased secretion of MMP9 protein | CTD | PMID:22626610 |
| cadmium atom | multiple interactions | ISO | RGD:621320 | 6480464 | Ipratropium promotes the reaction [formoterol inhibits the reaction [Cadmium results in increased activity of MMP9 protein]] | CTD | PMID:20826145 |
| cadmium dichloride | increases activity | ISO | RGD:621320 | 6480464 | Cadmium Chloride results in increased activity of MMP9 protein | CTD | PMID:20826145 |
| cadmium dichloride | multiple interactions | ISO | RGD:621320 | 6480464 | formoterol inhibits the reaction [Cadmium Chloride results in increased activity of MMP9 protein] | CTD | PMID:20826145 |
| calcium dichloride | increases expression | ISO | RGD:621320 | 6480464 | Calcium Chloride results in increased expression of MMP9 mRNA; more ... | CTD | PMID:20621845 |
| calcium dichloride | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Calcium Chloride results in increased activity of MMP9 protein] | CTD | PMID:21530968 |
| calcium dichloride | increases activity | EXP | | 6480464 | Calcium Chloride results in increased activity of MMP9 protein | CTD | PMID:21530968 |
| candesartan | decreases expression | ISO | RGD:621320 | 6480464 | candesartan results in decreased expression of MMP9 mRNA; more ... | CTD | PMID:19047581 |
| capsaicin | multiple interactions | ISO | RGD:1348437 | 6480464 | 4-aminobenzamide inhibits the reaction [Capsaicin results in increased activity of MMP9 protein]; more ... | CTD | PMID:21310942 |
| capsaicin | increases expression | ISO | RGD:1348437 | 6480464 | Capsaicin results in increased expression of MMP9 mRNA | CTD | PMID:21310942 PMID:22230393 |
| capsaicin | increases expression | ISO | RGD:1348437 | 6480464 | Capsaicin results in increased expression of MMP9 mRNA | CTD | PMID:22230393 PMID:21310942 |
| capsaicin | multiple interactions | ISO | RGD:1348437 | 6480464 | Capsaicin inhibits the reaction [EGF results in increased activity of MMP9 protein]; more ... | CTD | PMID:21462327 |
| carbon monoxide | increases expression | EXP | | 6480464 | Carbon Monoxide results in increased expression of MMP9 mRNA | CTD | PMID:20197249 |
| carvedilol | affects activity | ISO | RGD:1348437 | 6480464 | carvedilol affects the activity of MMP9 protein | CTD | PMID:16574429 |
| carvedilol | decreases activity | ISO | RGD:621320 | 6480464 | carvedilol results in decreased activity of MMP9 protein | CTD | PMID:16310260 |
| carvedilol | multiple interactions | ISO | RGD:1348437 | 6480464 | carvedilol inhibits the reaction [TNF protein results in increased expression of MMP9 protein] | CTD | PMID:17964422 |
| carvedilol | decreases expression | ISO | RGD:621320 | 6480464 | carvedilol results in decreased expression of MMP9 mRNA | CTD | PMID:18971572 |
| carvedilol | multiple interactions | ISO | RGD:621320 | 6480464 | carvedilol inhibits the reaction [Doxorubicin results in increased expression of MMP9 mRNA] | CTD | PMID:16213474 |
| celecoxib | multiple interactions | EXP | | 6480464 | celecoxib inhibits the reaction [Dihematoporphyrin Ether results in increased expression of MMP9 protein] | CTD | PMID:16230411 |
| celecoxib | multiple interactions | ISO | RGD:621320 | 6480464 | celecoxib promotes the reaction [Carbon Tetrachloride results in increased expression of MMP9 mRNA] | CTD | PMID:16420518 |
| CGS-21680 | decreases activity | ISO | RGD:1348437 | 6480464 | 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine results in decreased activity of MMP9 protein | CTD | PMID:16783407 |
| CGS-21680 | decreases expression | ISO | RGD:1348437 | 6480464 | 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine results in decreased expression of MMP9 mRNA | CTD | PMID:16783407 |
| chloroprene | decreases expression | EXP | | 6480464 | Chloroprene results in decreased expression of MMP9 mRNA | CTD | PMID:23125180 |
| chromium(6+) | increases expression | ISO | RGD:1348437 | 6480464 | chromium hexavalent ion results in increased expression of MMP9 protein | CTD | PMID:23518002 |
| cisplatin | decreases expression | ISO | RGD:1348437 | 6480464 | Cisplatin results in decreased expression of MMP9 | CTD | PMID:21789004 |
| cisplatin | decreases expression | ISO | RGD:621320 | 6480464 | Cisplatin results in decreased expression of MMP9 mRNA | CTD | PMID:22023808 |
| cisplatin | increases activity | ISO | RGD:1348437 | 6480464 | Cisplatin results in increased activity of MMP9 protein | CTD | PMID:21618587 |
| cisplatin | multiple interactions | ISO | RGD:1348437 | 6480464 | [[BSG binds to PPIA] which results in decreased susceptibility to Cisplatin] which results in increased expression of MMP9 | CTD | PMID:21956400 |
| clofibrate | decreases secretion | ISO | RGD:1348437 | 6480464 | Clofibrate results in decreased secretion of MMP9 protein | CTD | PMID:16860414 |
| cobalt atom | multiple interactions | ISO | RGD:1348437 | 6480464 | [tungsten carbide co-treated with Cobalt] results in decreased expression of MMP9 mRNA | CTD | PMID:18078969 |
| cocaine | multiple interactions | ISO | RGD:1348437 | 6480464 | Cocaine results in decreased expression of and results in decreased activity of MMP9 protein | CTD | PMID:18000554 |
| crocetin | multiple interactions | ISO | RGD:621320 | 6480464 | crocetin inhibits the reaction [Norepinephrine results in increased expression of MMP9 mRNA] | CTD | PMID:16864425 |
| crocidolite asbestos | increases expression | ISO | RGD:1348437 | 6480464 | Asbestos, Crocidolite results in increased expression of MMP9 protein | CTD | PMID:16966607 |
| curcumin | multiple interactions | ISO | RGD:1348437 | 6480464 | Curcumin inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA] | CTD | PMID:16219905 |
| curcumin | decreases activity | ISO | RGD:1348437 | 6480464 | Curcumin results in decreased activity of MMP9 protein | CTD | PMID:17996675 PMID:22771723 |
| curcumin | multiple interactions | ISO | RGD:1348437 | 6480464 | Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein] | CTD | PMID:20152819 PMID:21354279 |
| curcumin | multiple interactions | ISO | RGD:1348437 | 6480464 | Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] | CTD | PMID:20152819 more ... |
| curcumin | multiple interactions | ISO | RGD:1348437 | 6480464 | 4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine promotes the reaction [Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]]; more ... | CTD | PMID:20152819 |
| curcumin | decreases expression | ISO | RGD:1348437 | 6480464 | Curcumin results in decreased expression of MMP9 protein | CTD | PMID:17996675 PMID:18226269 |
| curcumin | multiple interactions | ISO | RGD:1348437 | 6480464 | Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein] | CTD | PMID:21354279 |
| curcumin | multiple interactions | ISO | RGD:1348437 | 6480464 | Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] | CTD | PMID:20599481 PMID:21354279 |
| curcumin | multiple interactions | ISO | RGD:1348437 | 6480464 | 3-caffeoyl-4-dihydrocaffeoylquinic acid promotes the reaction [Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]]; more ... | CTD | PMID:20599481 |
| curcumin | multiple interactions | ISO | RGD:1348437 | 6480464 | Curcumin inhibits the reaction [TNF protein results in increased expression of MMP9 protein] | CTD | PMID:20599780 more ... |
| curcumin | multiple interactions | ISO | RGD:1348437 | 6480464 | Curcumin inhibits the reaction [TNF protein results in increased expression of MMP9 protein] | CTD | PMID:17291458 more ... |
| curcumin | multiple interactions | ISO | RGD:1348437 | 6480464 | Curcumin inhibits the reaction [TNF protein results in increased expression of MMP9 protein] | CTD | PMID:17640567 more ... |
| curcumin | multiple interactions | ISO | RGD:1348437 | 6480464 | Curcumin analog inhibits the reaction [TNF protein results in increased expression of MMP9 protein] | CTD | PMID:20599780 |
| curcumin | multiple interactions | ISO | RGD:1348437 | 6480464 | Curcumin inhibits the reaction [TNF protein results in increased expression of MMP9 protein] | CTD | PMID:17291458 PMID:17640567 |
| curcumin | decreases expression | EXP | | 6480464 | Curcumin results in decreased expression of MMP9 protein | CTD | PMID:17440100 PMID:18829502 |
| curcumin | multiple interactions | ISO | RGD:1348437 | 6480464 | Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein] | CTD | PMID:18628248 |
| curcumin | multiple interactions | ISO | RGD:1348437 | 6480464 | Curcumin inhibits the reaction [Paclitaxel results in increased expression of MMP9 protein] | CTD | PMID:16243823 |
| curcumin | multiple interactions | ISO | RGD:1348437 | 6480464 | Curcumin inhibits the reaction [IL1B protein results in increased expression of MMP9 protein] | CTD | PMID:17291458 |
| curcumin | increases activity | ISO | RGD:621320 | 6480464 | Curcumin results in increased activity of MMP9 protein | CTD | PMID:17531121 |
| curcumin | multiple interactions | ISO | RGD:621320 | 6480464 | Curcumin inhibits the reaction [Ethanol results in increased expression of MMP9 mRNA] | CTD | PMID:17887948 |
| curcumin | affects expression | ISO | RGD:621320 | 6480464 | Curcumin affects the expression of MMP9 mRNA; more ... | CTD | PMID:18379247 |
| curcumin | decreases expression | EXP | | 6480464 | Curcumin results in decreased expression of MMP9 protein | CTD | PMID:18829502 PMID:17440100 |
| curcumin | multiple interactions | ISO | RGD:621320 | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [Curcumin results in increased activity of MMP9 protein] | CTD | PMID:17531121 |
| curcumin | multiple interactions | EXP | | 6480464 | [Curcumin co-treated with gemcitabine] results in decreased expression of MMP9 protein | CTD | PMID:17440100 |
| curcumin | multiple interactions | ISO | RGD:1348437 | 6480464 | TNFSF10 protein promotes the reaction [Curcumin results in decreased expression of MMP9 protein] | CTD | PMID:18226269 |
| curcumin | decreases expression | ISO | RGD:1348437 | 6480464 | Curcumin results in decreased expression of MMP9 protein | CTD | PMID:18226269 PMID:17996675 |
| curcumin | multiple interactions | ISO | RGD:1348437 | 6480464 | Glutathione inhibits the reaction [Curcumin inhibits the reaction [TNF protein results in increased expression of MMP9 protein]] | CTD | PMID:17640567 |
| curcumin | multiple interactions | ISO | RGD:1348437 | 6480464 | Curcumin results in decreased secretion of and results in decreased activity of MMP9 protein | CTD | PMID:18495463 |
| curcumin | multiple interactions | ISO | RGD:1348437 | 6480464 | Curcumin inhibits the reaction [VIP protein results in increased activity of MMP9 protein] | CTD | PMID:19189304 |
| curcumin | decreases activity | ISO | RGD:1348437 | 6480464 | Curcumin results in decreased activity of MMP9 protein | CTD | PMID:17996675 |
| curcumin | multiple interactions | ISO | RGD:1348437 | 6480464 | Curcumin inhibits the reaction [TNF protein results in increased expression of MMP9 protein] | CTD | PMID:17640567 PMID:17291458 |
| cysteamine | decreases activity | ISO | RGD:1348437 | 6480464 | Cysteamine results in decreased activity of MMP9 protein | CTD | PMID:22532830 |
| cysteamine | multiple interactions | ISO | RGD:1348437 | 6480464 | Cysteamine results in increased expression of and results in decreased activity of MMP9 protein | CTD | PMID:22532830 |
| cysteamine | increases expression | ISO | RGD:1348437 | 6480464 | Cysteamine results in increased expression of MMP9 mRNA | CTD | PMID:22532830 |
| cytochalasin D | multiple interactions | ISO | RGD:1348437 | 6480464 | Cytochalasin D promotes the reaction [TNF results in increased expression of MMP9 mRNA] | CTD | PMID:17560598 |
| D-glucose | increases activity | EXP | | 6480464 | Glucose results in increased activity of MMP9 protein | CTD | PMID:22543014 |
| D-glucose | multiple interactions | EXP | | 6480464 | pimagedine inhibits the reaction [Glucose results in increased activity of MMP9 protein] | CTD | PMID:22543014 |
| dapsone | multiple interactions | EXP | | 6480464 | Dapsone inhibits the reaction [Paraquat results in increased expression of MMP9 protein] | CTD | PMID:21765237 |
| delphinidin | multiple interactions | EXP | | 6480464 | delphinidin promotes the reaction [Carbon Tetrachloride results in increased expression of MMP9 protein] | CTD | PMID:20371262 |
| Delta(9)-tetrahydrocannabinol | increases expression | ISO | RGD:1348437 | 6480464 | Tetrahydrocannabinol results in increased expression of MMP9 mRNA | CTD | PMID:16330497 |
| Delta(9)-tetrahydrocannabinol | multiple interactions | ISO | RGD:1348437 | 6480464 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Tetrahydrocannabinol results in increased expression of MMP9 mRNA] | CTD | PMID:16330497 |
| demethoxycurcumin | multiple interactions | ISO | RGD:1348437 | 6480464 | demethoxycurcumin results in decreased secretion of and results in decreased activity of MMP9 protein | CTD | PMID:18495463 |
| dexamethasone | multiple interactions | EXP | | 6480464 | Dexamethasone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]; more ... | CTD | PMID:14515793 |
| dexamethasone | multiple interactions | ISO | RGD:621320 | 6480464 | Dexamethasone inhibits the reaction [Phosgene results in increased expression of MMP9 protein]; more ... | CTD | PMID:21941784 |
| dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of MMP9 mRNA | CTD | PMID:21041162 |
| dexamethasone | multiple interactions | ISO | RGD:621320 | 6480464 | Dexamethasone inhibits the reaction [IL1B protein results in increased activity of MMP9 protein]; more ... | CTD | PMID:15963473 |
| dexamethasone | affects expression | ISO | RGD:621320 | 6480464 | Dexamethasone affects the expression of MMP9 mRNA; more ... | CTD | PMID:18379247 |
| dextran sulfate | increases expression | EXP | | 6480464 | Dextran Sulfate results in increased expression of MMP9 protein; more ... | CTD | PMID:19285099 |
| dextran sulfate | multiple interactions | EXP | | 6480464 | Minocycline inhibits the reaction [Dextran Sulfate results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:19285099 |
| diallyl disulfide | multiple interactions | ISO | RGD:1348437 | 6480464 | diallyl disulfide results in decreased expression of and results in decreased activity of MMP9 protein | CTD | PMID:20600798 |
| diallyl disulfide | decreases expression | ISO | RGD:1348437 | 6480464 | diallyl disulfide results in decreased expression of MMP9 mRNA | CTD | PMID:20600798 |
| diarsenic trioxide | decreases expression | ISO | RGD:1348437 | 6480464 | arsenic trioxide results in decreased expression of MMP9 mRNA | CTD | PMID:16624393 more ... |
| diarsenic trioxide | decreases expression | ISO | RGD:1348437 | 6480464 | arsenic trioxide results in decreased expression of MMP9 protein | CTD | PMID:16624393 PMID:20592496 |
| diarsenic trioxide | decreases expression | ISO | RGD:1348437 | 6480464 | arsenic trioxide results in decreased expression of MMP9 mRNA | CTD | PMID:15962302 more ... |
| diarsenic trioxide | multiple interactions | ISO | RGD:1348437 | 6480464 | Acetylcysteine inhibits the reaction [arsenic trioxide results in decreased secretion of MMP9 protein]; more ... | CTD | PMID:15962302 |
| diarsenic trioxide | decreases expression | ISO | RGD:1348437 | 6480464 | arsenic trioxide results in decreased expression of MMP9 mRNA | CTD | PMID:16624393 more ... |
| diarsenic trioxide | decreases expression | ISO | RGD:1348437 | 6480464 | arsenic trioxide results in decreased expression of MMP9 mRNA | CTD | PMID:20471514 more ... |
| diarsenic trioxide | decreases expression | ISO | RGD:1348437 | 6480464 | arsenic trioxide results in decreased expression of MMP9 mRNA | CTD | PMID:19804631 more ... |
| diarsenic trioxide | decreases expression | ISO | RGD:1348437 | 6480464 | arsenic trioxide results in decreased expression of MMP9 mRNA | CTD | PMID:20471514 more ... |
| diarsenic trioxide | increases expression | ISO | RGD:1348437 | 6480464 | arsenic trioxide results in increased expression of MMP9 | CTD | PMID:15949266 |
| diarsenic trioxide | multiple interactions | ISO | RGD:1348437 | 6480464 | Acetylcysteine inhibits the reaction [arsenic trioxide results in decreased expression of MMP9 mRNA] | CTD | PMID:19350554 |
| diarsenic trioxide | decreases expression | ISO | RGD:1348437 | 6480464 | arsenic trioxide results in decreased expression of MMP9 protein | CTD | PMID:16624393 |
| diarsenic trioxide | decreases expression | ISO | RGD:1348437 | 6480464 | arsenic trioxide results in decreased expression of MMP9 mRNA | CTD | PMID:19804631 more ... |
| diarsenic trioxide | multiple interactions | ISO | RGD:1348437 | 6480464 | [acetyl-11-ketoboswellic acid co-treated with arsenic trioxide] results in decreased activity of MMP9 protein; more ... | CTD | PMID:21078271 |
| diarsenic trioxide | decreases expression | ISO | RGD:1348437 | 6480464 | arsenic trioxide results in decreased expression of MMP9 mRNA | CTD | PMID:19128835 more ... |
| diazoxide | increases expression | ISO | RGD:1348437 | 6480464 | Isoproterenol results in increased expression of MMP9 mRNA | CTD | PMID:16574429 |
| diazoxide | increases expression | ISO | RGD:621320 | 6480464 | Isoproterenol results in increased expression of MMP9 mRNA | CTD | PMID:18594475 |
| diazoxide | multiple interactions | ISO | RGD:621320 | 6480464 | CPU0213 inhibits the reaction [Isoproterenol results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:18594475 |
| diazoxide | increases activity | EXP | | 6480464 | Isoproterenol results in increased activity of MMP9 | CTD | PMID:18089841 |
| diazoxide | multiple interactions | EXP | | 6480464 | Doxycycline inhibits the reaction [Isoproterenol results in increased activity of MMP9] | CTD | PMID:18089841 |
| diazoxide | multiple interactions | ISO | RGD:1348437 | 6480464 | Propranolol inhibits the reaction [Isoproterenol results in increased expression of MMP9 mRNA] | CTD | PMID:16574429 |
| dibutyl phthalate | increases expression | ISO | RGD:621320 | 6480464 | Dibutyl Phthalate results in increased expression of MMP9 protein | CTD | PMID:19549552 |
| dicoumarol | multiple interactions | ISO | RGD:1348437 | 6480464 | Dicumarol inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:17669387 |
| diepoxybutane | decreases activity | ISO | RGD:621320 | 6480464 | erythritol anhydride results in decreased activity of MMP9 protein | CTD | PMID:12242682 |
| dimethyl sulfoxide | multiple interactions | ISO | RGD:621320 | 6480464 | Dimethyl Sulfoxide inhibits the reaction [Ethanol results in increased activity of MMP9 protein] | CTD | PMID:17603938 |
| dimethylarsinic acid | increases expression | EXP | | 6480464 | Cacodylic Acid results in increased expression of MMP9 mRNA | CTD | PMID:17441966 |
| dioxygen | increases expression | ISO | RGD:1348437 | 6480464 | Oxygen deficiency results in increased expression of MMP9 mRNA | CTD | PMID:18674879 |
| dioxygen | increases activity | ISO | RGD:1348437 | 6480464 | Oxygen deficiency results in increased activity of MMP9 protein | CTD | PMID:18674879 |
| dioxygen | multiple interactions | ISO | RGD:1348437 | 6480464 | resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 mRNA] | CTD | PMID:18674879 |
| disodium selenite | multiple interactions | ISO | RGD:621320 | 6480464 | Sodium Selenite inhibits the reaction [sodium arsenite results in increased secretion of MMP9 protein] | CTD | PMID:19933942 |
| disodium selenite | multiple interactions | EXP | | 6480464 | [ptaquiloside co-treated with Sodium Selenite] results in decreased expression of MMP9 mRNA | CTD | PMID:23274088 |
| disulfiram | decreases expression | ISO | RGD:1348437 | 6480464 | Disulfiram results in decreased expression of MMP9 | CTD | PMID:18047805 |
| docetaxel anhydrous | multiple interactions | ISO | RGD:1348437 | 6480464 | [O-(chloroacetylcarbamoyl)fumagillol co-treated with docetaxel] results in decreased expression of MMP9 protein | CTD | PMID:12576464 |
| doxorubicin | affects expression | ISO | RGD:1348437 | 6480464 | Doxorubicin affects the expression of MMP9 mRNA | CTD | PMID:15205334 |
| doxorubicin | decreases expression | ISO | RGD:621320 | 6480464 | Doxorubicin results in decreased expression of MMP9 protein; more ... | CTD | PMID:19801496 PMID:19357873 |
| doxorubicin | decreases expression | ISO | RGD:621320 | 6480464 | Doxorubicin results in decreased expression of MMP9 mRNA; more ... | CTD | PMID:19357873 PMID:19801496 |
| doxorubicin | multiple interactions | ISO | RGD:621320 | 6480464 | benazepril inhibits the reaction [Doxorubicin results in decreased expression of MMP9 protein]; more ... | CTD | PMID:19357873 |
| doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of MMP9 mRNA | CTD | PMID:16455267 PMID:19286953 |
| doxorubicin | increases expression | ISO | RGD:621320 | 6480464 | Doxorubicin results in increased expression of MMP9 mRNA | CTD | PMID:16213474 |
| doxorubicin | increases activity | ISO | RGD:621320 | 6480464 | Doxorubicin results in increased activity of MMP9 protein | CTD | PMID:16213474 |
| doxorubicin | decreases expression | ISO | RGD:621320 | 6480464 | Doxorubicin results in decreased expression of MMP9 mRNA; more ... | CTD | PMID:19801496 |
| doxorubicin | multiple interactions | ISO | RGD:621320 | 6480464 | Acetylcysteine inhibits the reaction [Doxorubicin results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:16213474 |
| doxorubicin | multiple interactions | EXP | | 6480464 | tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex inhibits the reaction [Doxorubicin results in increased expression of MMP9 mRNA] | CTD | PMID:19286953 |
| doxorubicin | decreases response to substance | EXP | | 6480464 | MMP9 gene mutant form results in decreased susceptibility to Doxorubicin | CTD | PMID:20407279 |
| doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of MMP9 mRNA | CTD | PMID:19286953 PMID:16455267 |
| doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of MMP9 mRNA | CTD | PMID:15033991 |
| doxycycline | multiple interactions | EXP | | 6480464 | Doxycycline inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:15131573 |
| doxycycline | multiple interactions | ISO | RGD:621320 | 6480464 | Doxycycline inhibits the reaction [AGT protein modified form results in increased activity of MMP9 protein] | CTD | PMID:20837116 |
| doxycycline | decreases activity | ISO | RGD:621320 | 6480464 | Doxycycline results in decreased activity of MMP9 protein | CTD | PMID:20837116 |
| doxycycline | multiple interactions | ISO | RGD:1348437 | 6480464 | Doxycycline inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein] | CTD | PMID:17498959 |
| doxycycline | multiple interactions | ISO | RGD:1348437 | 6480464 | Doxycycline inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein] | CTD | PMID:19375915 |
| doxycycline | decreases expression | EXP | | 6480464 | Doxycycline results in decreased expression of MMP9 protein | CTD | PMID:18178469 |
| doxycycline | multiple interactions | EXP | | 6480464 | Doxycycline inhibits the reaction [Isoproterenol results in increased activity of MMP9] | CTD | PMID:18089841 |
| edaravone | multiple interactions | ISO | RGD:621320 | 6480464 | phenylmethylpyrazolone inhibits the reaction [PLAT protein results in increased expression of and results in increased activity of MMP9 protein]; more ... | CTD | PMID:19095969 |
| elemental selenium | decreases expression | ISO | RGD:1348437 | 6480464 | Selenium results in decreased expression of MMP9 mRNA | CTD | PMID:17390030 |
| ethanol | multiple interactions | ISO | RGD:621320 | 6480464 | Acetylcysteine inhibits the reaction [Ethanol results in increased secretion of and results in increased activity of MMP9 protein]; more ... | CTD | PMID:17603938 |
| ethanol | increases expression | ISO | RGD:621320 | 6480464 | Ethanol results in increased expression of MMP9 protein | CTD | PMID:23155471 |
| ethanol | increases expression | ISO | RGD:621320 | 6480464 | Ethanol results in increased expression of MMP9 mRNA | CTD | PMID:17603938 more ... |
| ethanol | multiple interactions | ISO | RGD:621320 | 6480464 | [Ethanol co-treated with Dietary Fats] results in increased expression of MMP9 mRNA; more ... | CTD | PMID:21051528 |
| ethanol | multiple interactions | ISO | RGD:621320 | 6480464 | Ethanol affects the reaction [ochratoxin A results in increased expression of MMP9 protein] | CTD | PMID:16622519 |
| ethanol | increases expression | ISO | RGD:621320 | 6480464 | Ethanol results in increased expression of MMP9 mRNA | CTD | PMID:17603938 PMID:17887948 |
| ethanol | multiple interactions | ISO | RGD:621320 | 6480464 | Curcumin inhibits the reaction [Ethanol results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:17887948 |
| ethanol | increases expression | ISO | RGD:621320 | 6480464 | Ethanol results in increased expression of MMP9 mRNA | CTD | PMID:17887948 PMID:17603938 |
| etodolac | decreases expression | EXP | | 6480464 | Etodolac results in decreased expression of MMP9 mRNA | CTD | PMID:16391837 |
| eugenol | multiple interactions | ISO | RGD:621320 | 6480464 | Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of and results in increased activity of MMP9 protein]; more ... | CTD | PMID:20434464 |
| famotidine | multiple interactions | ISO | RGD:621320 | 6480464 | Famotidine inhibits the reaction [Ethanol results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:17603938 |
| farnesyl diphosphate | multiple interactions | ISO | RGD:621320 | 6480464 | farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Smoke analog results in increased expression of MMP9 mRNA]]; more ... | CTD | PMID:19299917 |
| fenofibrate | multiple interactions | ISO | RGD:1348437 | 6480464 | Fenofibrate inhibits the reaction [Lipopolysaccharides results in increased secretion of MMP9 protein] | CTD | PMID:21075133 |
| fenofibrate | multiple interactions | ISO | RGD:1348437 | 6480464 | Fenofibrate inhibits the reaction [Dinoprostone results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:19880272 |
| fisetin | multiple interactions | ISO | RGD:1348437 | 6480464 | fisetin inhibits the reaction [Silicon Dioxide results in increased expression of MMP9 mRNA] | CTD | PMID:22931364 |
| fluoxetine | multiple interactions | EXP | | 6480464 | Fluoxetine inhibits the reaction [TNFSF11 protein results in increased expression of MMP9 mRNA] | CTD | PMID:15312242 |
| fluoxetine | decreases activity | ISO | RGD:621320 | 6480464 | Fluoxetine results in decreased activity of MMP9 protein | CTD | PMID:21966942 |
| flurbiprofen | multiple interactions | ISO | RGD:1348437 | 6480464 | [[Flurbiprofen results in increased expression of TIMP1 protein] which results in decreased expression of MMP9 mRNA] which results in decreased degradation of HPGD protein | CTD | PMID:19501039 |
| flurbiprofen | decreases expression | ISO | RGD:1348437 | 6480464 | Flurbiprofen results in decreased expression of MMP9 mRNA | CTD | PMID:19501039 |
| folic acid | multiple interactions | ISO | RGD:621320 | 6480464 | Dizocilpine Maleate inhibits the reaction [Folic Acid deficiency results in decreased expression of MMP9 mRNA] | CTD | PMID:20406136 |
| folic acid | decreases expression | ISO | RGD:621320 | 6480464 | Folic Acid deficiency results in decreased expression of MMP9 mRNA | CTD | PMID:20406136 |
| folic acid | decreases activity | ISO | RGD:621320 | 6480464 | Folic Acid deficiency results in decreased activity of MMP9 protein | CTD | PMID:20406136 |
| formoterol | multiple interactions | ISO | RGD:621320 | 6480464 | Ipratropium promotes the reaction [formoterol inhibits the reaction [Cadmium results in increased activity of MMP9 protein]]; more ... | CTD | PMID:20826145 |
| fulvestrant | multiple interactions | ISO | RGD:1348437 | 6480464 | fulvestrant inhibits the reaction [bisphenol A results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:19956873 |
| gadolinium trichloride | increases expression | ISO | RGD:621320 | 6480464 | gadolinium chloride results in increased expression of MMP9 mRNA | CTD | PMID:12493575 |
| gadolinium trichloride | multiple interactions | ISO | RGD:621320 | 6480464 | SB 203580 inhibits the reaction [gadolinium chloride results in increased expression of MMP9 mRNA] | CTD | PMID:12493575 |
| gallic acid | decreases expression | EXP | | 6480464 | Gallic Acid results in decreased expression of MMP9 mRNA | CTD | PMID:16304905 |
| gallic acid | decreases activity | ISO | RGD:1348437 | 6480464 | Gallic Acid results in decreased activity of MMP9 protein | CTD | PMID:22387266 |
| gallic acid | decreases expression | ISO | RGD:1348437 | 6480464 | Gallic Acid results in decreased expression of MMP9 mRNA; more ... | CTD | PMID:22387266 |
| gefitinib | multiple interactions | EXP | | 6480464 | gefitinib inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA] | CTD | PMID:15841081 |
| genistein | decreases activity | ISO | RGD:1348437 | 6480464 | Genistein results in decreased activity of MMP9 protein | CTD | PMID:16598420 |
| genistein | decreases expression | ISO | RGD:1348437 | 6480464 | Genistein results in decreased expression of MMP9 mRNA | CTD | PMID:15754008 PMID:15256057 |
| genistein | decreases expression | ISO | RGD:1348437 | 6480464 | Genistein results in decreased expression of MMP9 protein | CTD | PMID:15256057 |
| genistein | decreases expression | ISO | RGD:1348437 | 6480464 | Genistein results in decreased expression of MMP9 mRNA | CTD | PMID:15256057 PMID:15754008 |
| glucose | increases activity | EXP | | 6480464 | Glucose results in increased activity of MMP9 protein | CTD | PMID:22543014 |
| glucose | multiple interactions | EXP | | 6480464 | pimagedine inhibits the reaction [Glucose results in increased activity of MMP9 protein] | CTD | PMID:22543014 |
| glutathione | affects binding | ISO | RGD:1348437 | 6480464 | Glutathione binds to MMP9 protein | CTD | PMID:17015178 |
| glutathione | multiple interactions | EXP | | 6480464 | Glutathione inhibits the reaction [2-chloroethyl ethyl sulfide results in increased expression of MMP9 protein] | CTD | PMID:21722719 |
| glutathione | decreases secretion | ISO | RGD:1348437 | 6480464 | Glutathione results in decreased secretion of MMP9 protein | CTD | PMID:15147517 |
| glutathione | multiple interactions | ISO | RGD:1348437 | 6480464 | Glutathione inhibits the reaction [Curcumin inhibits the reaction [TNF protein results in increased expression of MMP9 protein]] | CTD | PMID:17640567 |
| glutathione | multiple interactions | ISO | RGD:1348437 | 6480464 | Glutathione inhibits the reaction [4-aminophenylmercuriacetate results in increased activity of MMP9 protein]; more ... | CTD | PMID:17015178 |
| Goe 6976 | multiple interactions | ISO | RGD:1348437 | 6480464 | Go 6976 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] | CTD | PMID:19804834 |
| Goe 6976 | multiple interactions | ISO | RGD:1348437 | 6480464 | Go 6976 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of and results in increased activity of MMP9 protein] | CTD | PMID:20152819 |
| Goe 6976 | multiple interactions | ISO | RGD:1348437 | 6480464 | Go 6976 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:21354279 |
| heparin | decreases activity | ISO | RGD:1348437 | 6480464 | Heparin results in decreased activity of MMP9 protein | CTD | PMID:10958381 |
| heparin | increases expression | EXP | | 6480464 | Heparin results in increased expression of MMP9 mRNA | CTD | PMID:14630814 PMID:16190367 |
| heparin | multiple interactions | EXP | | 6480464 | Heparin results in increased metabolism of and results in increased activity of MMP9 protein | CTD | PMID:14630814 |
| heparin | increases expression | EXP | | 6480464 | Heparin results in increased expression of MMP9 protein | CTD | PMID:16190367 |
| heparin | increases expression | EXP | | 6480464 | Heparin results in increased expression of MMP9 mRNA | CTD | PMID:16190367 PMID:14630814 |
| hesperidin | multiple interactions | ISO | RGD:1348437 | 6480464 | Hesperidin inhibits the reaction [Acetaldehyde results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:19110045 |
| hesperidin | multiple interactions | ISO | RGD:1348437 | 6480464 | Hesperidin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] | CTD | PMID:20138977 |
| hesperidin | decreases secretion | ISO | RGD:1348437 | 6480464 | Hesperidin results in decreased secretion of MMP9 protein | CTD | PMID:19110045 |
| hexachlorobenzene | increases expression | ISO | RGD:621320 | 6480464 | Hexachlorobenzene results in increased expression of MMP9 mRNA | CTD | PMID:15159207 |
| hyaluronic acid | affects activity | EXP | | 6480464 | Hyaluronic Acid affects the activity of MMP9 protein | CTD | PMID:15597151 |
| hydrogen peroxide | increases secretion | ISO | RGD:1348437 | 6480464 | Hydrogen Peroxide results in increased secretion of MMP9 protein | CTD | PMID:15531749 |
| hydrogen peroxide | increases expression | ISO | RGD:1348437 | 6480464 | Hydrogen Peroxide results in increased expression of MMP9 protein | CTD | PMID:15531749 |
| hydrogen peroxide | increases activity | ISO | RGD:1348437 | 6480464 | Hydrogen Peroxide results in increased activity of MMP9 protein | CTD | PMID:15531749 |
| hydroquinone | multiple interactions | ISO | RGD:1348437 | 6480464 | hydroquinone inhibits the reaction [Dicumarol inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of MMP9 protein]]; more ... | CTD | PMID:17669387 |
| hydroxytyrosol | multiple interactions | ISO | RGD:1348437 | 6480464 | 3,4-dihydroxyphenylethanol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:22595400 |
| ibuprofen | multiple interactions | ISO | RGD:1348437 | 6480464 | Ibuprofen inhibits the reaction [EGF protein results in increased activity of MMP9 protein]; more ... | CTD | PMID:16340751 |
| ifosfamide | multiple interactions | EXP | | 6480464 | IFNA2 promotes the reaction [Ifosfamide results in decreased activity of MMP9 protein]; more ... | CTD | PMID:15659795 |
| ifosfamide | decreases activity | EXP | | 6480464 | Ifosfamide results in decreased activity of MMP9 protein | CTD | PMID:15659795 |
| ifosfamide | affects expression | EXP | | 6480464 | Ifosfamide affects the expression of MMP9 mRNA | CTD | PMID:15659795 |
| imiquimod | decreases activity | EXP | | 6480464 | imiquimod results in decreased activity of MMP9 protein | CTD | PMID:14708627 |
| indinavir | multiple interactions | ISO | RGD:621320 | 6480464 | Indinavir inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:14662518 |
| indole-3-methanol | multiple interactions | ISO | RGD:1348437 | 6480464 | indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of MMP9 protein] | CTD | PMID:15811958 |
| indomethacin | multiple interactions | EXP | | 6480464 | Indomethacin inhibits the reaction [Croton Oil results in increased expression of MMP9 protein]; more ... | CTD | PMID:14515793 |
| indomethacin | multiple interactions | ISO | RGD:621320 | 6480464 | Indomethacin results in increased expression of and results in increased secretion of MMP9 protein; more ... | CTD | PMID:16150113 |
| indomethacin | multiple interactions | ISO | RGD:621320 | 6480464 | Indomethacin results in increased expression of and results in increased secretion of and results in increased activity of MMP9 protein | CTD | PMID:16934674 |
| indomethacin | decreases activity | ISO | RGD:621320 | 6480464 | Indomethacin results in decreased activity of MMP9 protein | CTD | PMID:10231640 |
| indomethacin | increases activity | ISO | RGD:621320 | 6480464 | Indomethacin results in increased activity of MMP9 protein | CTD | PMID:10878458 |
| indomethacin | multiple interactions | EXP | | 6480464 | [Indomethacin co-treated with Medroxyprogesterone Acetate] results in decreased activity of MMP9 protein | CTD | PMID:16537180 |
| indomethacin | decreases activity | EXP | | 6480464 | Indomethacin results in decreased activity of MMP9 protein | CTD | PMID:16537180 |
| indomethacin | multiple interactions | ISO | RGD:1348437 | 6480464 | Indomethacin results in decreased expression of and results in decreased activity of MMP9 protein | CTD | PMID:11719597 |
| ipratropium | multiple interactions | ISO | RGD:621320 | 6480464 | Ipratropium promotes the reaction [formoterol inhibits the reaction [Cadmium results in increased activity of MMP9 protein]] | CTD | PMID:20826145 |
| isoprenaline | multiple interactions | ISO | RGD:1348437 | 6480464 | Propranolol inhibits the reaction [Isoproterenol results in increased expression of MMP9 mRNA] | CTD | PMID:16574429 |
| isoprenaline | multiple interactions | ISO | RGD:621320 | 6480464 | CPU0213 inhibits the reaction [Isoproterenol results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:18594475 |
| isoprenaline | increases expression | ISO | RGD:621320 | 6480464 | Isoproterenol results in increased expression of MMP9 mRNA | CTD | PMID:18594475 |
| isoprenaline | increases activity | EXP | | 6480464 | Isoproterenol results in increased activity of MMP9 | CTD | PMID:18089841 |
| isoprenaline | multiple interactions | EXP | | 6480464 | Doxycycline inhibits the reaction [Isoproterenol results in increased activity of MMP9] | CTD | PMID:18089841 |
| isoprenaline | increases expression | ISO | RGD:1348437 | 6480464 | Isoproterenol results in increased expression of MMP9 mRNA | CTD | PMID:16574429 |
| isotretinoin | multiple interactions | ISO | RGD:1348437 | 6480464 | Isotretinoin inhibits the reaction [Arachidonic Acid results in increased secretion of MMP9 protein]; more ... | CTD | PMID:16185265 |
| isotretinoin | decreases expression | ISO | RGD:1348437 | 6480464 | Isotretinoin results in decreased expression of MMP9 protein | CTD | PMID:16185265 |
| lead diacetate | increases expression | EXP | | 6480464 | lead acetate results in increased expression of MMP9 mRNA | CTD | PMID:20542052 |
| leukotriene B4 | increases expression | EXP | | 6480464 | Leukotriene B4 results in increased expression of MMP9 protein | CTD | PMID:19837106 |
| leukotriene B4 | multiple interactions | EXP | | 6480464 | SB 203580 inhibits the reaction [Leukotriene B4 results in increased expression of MMP9 protein]; more ... | CTD | PMID:19837106 |
| leukotriene C4 | multiple interactions | EXP | | 6480464 | PD 98059 inhibits the reaction [Leukotriene C4 results in increased expression of MMP9 protein]; more ... | CTD | PMID:19837106 |
| leukotriene C4 | increases expression | EXP | | 6480464 | Leukotriene C4 results in increased expression of MMP9 protein | CTD | PMID:19837106 |
| leukotriene D4 | multiple interactions | EXP | | 6480464 | PD 98059 inhibits the reaction [Leukotriene D4 results in increased expression of MMP9 protein]; more ... | CTD | PMID:19837106 |
| leukotriene D4 | increases expression | EXP | | 6480464 | Leukotriene D4 results in increased expression of MMP9 protein | CTD | PMID:19837106 |
| losartan | decreases expression | ISO | RGD:621320 | 6480464 | Losartan results in decreased expression of MMP9 mRNA | CTD | PMID:18971572 |
| lovastatin | decreases expression | ISO | RGD:1348437 | 6480464 | Lovastatin results in decreased expression of MMP9 protein | CTD | PMID:19360310 |
| luteolin | multiple interactions | ISO | RGD:1348437 | 6480464 | Luteolin inhibits the reaction [EGF protein results in increased secretion of MMP9 protein] | CTD | PMID:15135307 |
| luteolin | multiple interactions | EXP | | 6480464 | Luteolin inhibits the reaction [Carbon Tetrachloride results in decreased expression of MMP9 protein] | CTD | PMID:19747501 |
| luteolin | decreases secretion | ISO | RGD:1348437 | 6480464 | Luteolin results in decreased secretion of MMP9 protein | CTD | PMID:15135307 |
| LY294002 | multiple interactions | ISO | RGD:1348437 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [butein results in decreased expression of MMP9 protein] | CTD | PMID:20696233 |
| LY294002 | multiple interactions | ISO | RGD:1348437 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Oxidopamine results in increased expression of MMP9 mRNA] | CTD | PMID:19962414 |
| LY294002 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of MMP9 mRNA] | CTD | PMID:19962414 |
| LY294002 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA] | CTD | PMID:19401153 |
| LY294002 | multiple interactions | ISO | RGD:1348437 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] | CTD | PMID:19447859 |
| LY294002 | multiple interactions | ISO | RGD:1348437 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [bisphenol A results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:19956873 |
| LY294002 | decreases expression | ISO | RGD:1348437 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of MMP9 protein | CTD | PMID:18424783 |
| LY294002 | multiple interactions | ISO | RGD:621320 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Smoke analog results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:19299917 |
| LY294002 | multiple interactions | ISO | RGD:1348437 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [TNF results in increased expression of MMP9 mRNA] | CTD | PMID:17560598 |
| LY294002 | decreases expression | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of MMP9 mRNA | CTD | PMID:19393235 |
| LY294002 | decreases activity | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased activity of MMP9 protein | CTD | PMID:19393235 |
| LY294002 | decreases expression | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of MMP9 mRNA | CTD | PMID:19393235 PMID:22326785 |
| LY294002 | decreases activity | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased activity of MMP9 protein | CTD | PMID:19393235 PMID:22326785 |
| LY294002 | multiple interactions | ISO | RGD:1348437 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [VEGFA protein results in increased activity of MMP9 protein] | CTD | PMID:22270366 |
| mechlorethamine | increases expression | ISO | RGD:621320 | 6480464 | Mechlorethamine results in increased expression of MMP9 protein | CTD | PMID:20883710 |
| medroxyprogesterone acetate | multiple interactions | EXP | | 6480464 | [Indomethacin co-treated with Medroxyprogesterone Acetate] results in decreased activity of MMP9 protein | CTD | PMID:16537180 |
| medroxyprogesterone acetate | decreases activity | EXP | | 6480464 | Medroxyprogesterone Acetate results in decreased activity of MMP9 protein | CTD | PMID:16537180 |
| melatonin | multiple interactions | ISO | RGD:621320 | 6480464 | Melatonin inhibits the reaction [Indomethacin results in increased expression of and results in increased secretion of MMP9 protein] | CTD | PMID:16150113 |
| mercury atom | affects response to substance | ISO | RGD:1348437 | 6480464 | MMP9 promoter polymorphism affects the susceptibility to Mercury | CTD | PMID:20554312 |
| mercury(0) | affects response to substance | ISO | RGD:1348437 | 6480464 | MMP9 promoter polymorphism affects the susceptibility to Mercury | CTD | PMID:20554312 |
| metformin | multiple interactions | ISO | RGD:1348437 | 6480464 | Metformin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]; more ... | CTD | PMID:20590612 |
| metformin | decreases activity | ISO | RGD:1348437 | 6480464 | Metformin results in decreased activity of MMP9 protein | CTD | PMID:20590612 |
| methamphetamine | multiple interactions | ISO | RGD:1348437 | 6480464 | [HIV Envelope Protein gp120 co-treated with Methamphetamine] promotes the reaction [lipopolysaccharide, E. coli 026-B6 results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:21425912 |
| methamphetamine | increases response to substance | EXP | | 6480464 | MMP9 protein results in increased susceptibility to Methamphetamine | CTD | PMID:18198472 |
| methamphetamine | increases expression | EXP | | 6480464 | Methamphetamine results in increased expression of MMP9 | CTD | PMID:18766021 |
| methamphetamine | increases activity | EXP | | 6480464 | Methamphetamine results in increased activity of MMP9 protein | CTD | PMID:18198472 |
| metoprolol | decreases expression | ISO | RGD:1348437 | 6480464 | Metoprolol results in decreased expression of MMP9 mRNA; more ... | CTD | PMID:20424515 |
| metoprolol | decreases secretion | ISO | RGD:1348437 | 6480464 | Metoprolol results in decreased secretion of MMP9 protein | CTD | PMID:20424515 |
| mevalonic acid | multiple interactions | ISO | RGD:1348437 | 6480464 | Mevalonic Acid inhibits the reaction [Simvastatin inhibits the reaction [[IL1A co-treated with PDGFB] results in increased secretion of MMP9 protein]]; more ... | CTD | PMID:15728660 |
| microcystin-LR | increases expression | EXP | | 6480464 | cyanoginosin LR results in increased expression of MMP9 mRNA; more ... | CTD | PMID:20934494 |
| mifepristone | multiple interactions | ISO | RGD:621320 | 6480464 | Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [IL1B protein results in increased activity of MMP9 protein]]; more ... | CTD | PMID:15963473 |
| minocycline | multiple interactions | EXP | | 6480464 | Minocycline inhibits the reaction [FMR1 gene mutant form results in increased expression of and results in increased activity of MMP9 protein] | CTD | PMID:18835858 |
| minocycline | multiple interactions | EXP | | 6480464 | Minocycline inhibits the reaction [Dextran Sulfate results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:19285099 |
| minocycline | decreases activity | ISO | RGD:621320 | 6480464 | Minocycline results in decreased activity of MMP9 protein | CTD | PMID:16846501 |
| minocycline | decreases expression | ISO | RGD:621320 | 6480464 | Minocycline results in decreased expression of MMP9 protein | CTD | PMID:16846501 |
| morphine | multiple interactions | EXP | | 6480464 | MMP9 protein affects the reaction [Morphine results in increased phosphorylation of GRIN1 protein]; more ... | CTD | PMID:20519536 |
| morphine | increases activity | EXP | | 6480464 | Morphine results in increased activity of MMP9 protein | CTD | PMID:20519536 |
| myricetin | multiple interactions | ISO | RGD:1348437 | 6480464 | myricetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] | CTD | PMID:19804834 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:1348437 | 6480464 | Acetylcysteine inhibits the reaction [4-aminophenylmercuriacetate results in increased activity of MMP9 protein] | CTD | PMID:17015178 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of MMP9 mRNA] | CTD | PMID:19962414 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:1348437 | 6480464 | Acetylcysteine inhibits the reaction [Oxidopamine results in increased expression of MMP9 mRNA] | CTD | PMID:19962414 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:1348437 | 6480464 | Acetylcysteine inhibits the reaction [arsenic trioxide results in decreased secretion of MMP9 protein] | CTD | PMID:15962302 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:621320 | 6480464 | [Ethanol co-treated with Dietary Fats co-treated with Acetylcysteine] results in increased expression of MMP9 mRNA | CTD | PMID:21051528 |
| N-acetyl-L-cysteine | decreases activity | ISO | RGD:1348437 | 6480464 | Acetylcysteine results in decreased activity of MMP9 protein | CTD | PMID:18930813 |
| N-acetyl-L-cysteine | decreases activity | ISO | RGD:621320 | 6480464 | Acetylcysteine results in decreased activity of MMP9 protein | CTD | PMID:15451797 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:621320 | 6480464 | Acetylcysteine inhibits the reaction [Ethanol results in increased secretion of and results in increased activity of MMP9 protein] | CTD | PMID:17603938 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:621320 | 6480464 | Acetylcysteine inhibits the reaction [Doxorubicin results in increased expression of MMP9 mRNA] | CTD | PMID:16213474 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA] | CTD | PMID:15557194 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:1348437 | 6480464 | Acetylcysteine inhibits the reaction [arsenic trioxide results in decreased expression of MMP9 mRNA] | CTD | PMID:19350554 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:1348437 | 6480464 | Acetylcysteine inhibits the reaction [Homocysteine results in increased activity of MMP9 protein]; more ... | CTD | PMID:16251475 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:1348437 | 6480464 | Acetylcysteine inhibits the reaction [Acrolein results in increased expression of MMP9 protein] | CTD | PMID:19371603 |
| N-methyl-4-phenylpyridinium | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:19962414 |
| N-methyl-4-phenylpyridinium | increases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of MMP9 mRNA | CTD | PMID:19962414 |
| N-methyl-N'-nitro-N-nitrosoguanidine | multiple interactions | ISO | RGD:621320 | 6480464 | Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:20434464 |
| N-methyl-N'-nitro-N-nitrosoguanidine | increases expression | ISO | RGD:621320 | 6480464 | Methylnitronitrosoguanidine results in increased expression of MMP9 mRNA | CTD | PMID:20434464 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | CCL3 protein affects the reaction [Diethylnitrosamine results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:16284949 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:621320 | 6480464 | morin inhibits the reaction [Diethylnitrosamine results in increased expression of MMP9 protein] | CTD | PMID:19539802 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:621320 | 6480464 | Diethylnitrosamine results in increased expression of MMP9 protein | CTD | PMID:19539802 |
| N-nitrosodiethylamine | increases activity | ISO | RGD:621320 | 6480464 | Diethylnitrosamine results in increased activity of MMP9 protein | CTD | PMID:19052882 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:621320 | 6480464 | bacoside A inhibits the reaction [Diethylnitrosamine results in increased expression of and results in increased activity of MMP9 protein] | CTD | PMID:20084675 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:621320 | 6480464 | [Diethylnitrosamine co-treated with 2-aminofluorene] results in increased expression of MMP9 protein; more ... | CTD | PMID:19052882 |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of MMP9 mRNA; more ... | CTD | PMID:16284949 |
| N-nitrosodimethylamine | increases activity | ISO | RGD:621320 | 6480464 | Dimethylnitrosamine results in increased activity of MMP9 protein | CTD | PMID:15161499 |
| N-tosyl-L-phenylalanyl chloromethyl ketone | decreases activity | ISO | RGD:1348437 | 6480464 | Tosylphenylalanyl Chloromethyl Ketone results in decreased activity of MMP9 protein | CTD | PMID:22033475 |
| naloxone | multiple interactions | EXP | | 6480464 | [Morphine co-treated with Naloxone] results in increased activity of MMP9 protein; more ... | CTD | PMID:20519536 |
| naphthalene | increases expression | EXP | | 6480464 | naphthalene results in increased expression of MMP9 mRNA | CTD | PMID:18978301 |
| nickel atom | multiple interactions | ISO | RGD:1348437 | 6480464 | 17-(allylamino)-17-demethoxygeldanamycin affects the reaction [Nickel results in increased activity of MMP9 protein]; more ... | CTD | PMID:21401309 |
| nickel atom | increases expression | ISO | RGD:1348437 | 6480464 | Nickel results in increased expression of MMP9 mRNA | CTD | PMID:21401309 |
| nickel atom | increases activity | ISO | RGD:1348437 | 6480464 | Nickel results in increased activity of MMP9 protein | CTD | PMID:21401309 |
| nickel dichloride | increases expression | ISO | RGD:1348437 | 6480464 | nickel chloride results in increased expression of MMP9 protein | CTD | PMID:21473897 |
| nickel sulfate | increases expression | ISO | RGD:1348437 | 6480464 | nickel sulfate results in increased expression of MMP9 mRNA | CTD | PMID:18651567 |
| nickel sulfate | multiple interactions | ISO | RGD:1348437 | 6480464 | nickel sulfate results in increased expression of and results in increased secretion of MMP9 protein | CTD | PMID:15020194 |
| nifedipine | multiple interactions | ISO | RGD:1348437 | 6480464 | Nifedipine results in decreased expression of and results in decreased activity of MMP9 protein | CTD | PMID:18204791 |
| nimesulide | decreases expression | ISO | RGD:1348437 | 6480464 | nimesulide results in decreased expression of MMP9 mRNA; more ... | CTD | PMID:21176579 |
| nitric oxide | increases expression | EXP | | 6480464 | Nitric Oxide results in increased expression of MMP9 mRNA | CTD | PMID:20197249 |
| nitroglycerin | increases activity | ISO | RGD:1348437 | 6480464 | Nitroglycerin results in increased activity of MMP9 protein | CTD | PMID:12084592 |
| nitroglycerin | increases expression | ISO | RGD:1348437 | 6480464 | Nitroglycerin results in increased expression of MMP9 mRNA | CTD | PMID:12084592 |
| NS-398 | multiple interactions | ISO | RGD:1348437 | 6480464 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [HGF results in increased expression of MMP9] | CTD | PMID:11981761 |
| NS-398 | multiple interactions | ISO | RGD:1348437 | 6480464 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]; more ... | CTD | PMID:19804834 |
| NS-398 | multiple interactions | ISO | RGD:1348437 | 6480464 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [anandamide results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:16330497 |
| ochratoxin A | increases expression | ISO | RGD:621320 | 6480464 | ochratoxin A results in increased expression of MMP9 protein | CTD | PMID:16622519 |
| ochratoxin A | multiple interactions | ISO | RGD:621320 | 6480464 | Ethanol affects the reaction [ochratoxin A results in increased expression of MMP9 protein] | CTD | PMID:16622519 |
| oroxylin A | decreases expression | ISO | RGD:1348437 | 6480464 | 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one results in decreased expression of MMP9 protein; more ... | CTD | PMID:22245252 |
| oroxylin A | multiple interactions | ISO | RGD:1348437 | 6480464 | 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein] | CTD | PMID:22245252 |
| ozone | multiple interactions | EXP | | 6480464 | MMP9 gene mutant form promotes the reaction [Ozone results in increased activity of MMP2 protein]; more ... | CTD | PMID:18007984 |
| ozone | increases expression | EXP | | 6480464 | Ozone results in increased expression of MMP9 mRNA | CTD | PMID:12763055 PMID:18007984 |
| ozone | increases activity | EXP | | 6480464 | Ozone results in increased activity of MMP9 protein | CTD | PMID:18007984 PMID:12763055 |
| ozone | increases expression | EXP | | 6480464 | Ozone results in increased expression of MMP9 protein | CTD | PMID:18007984 |
| ozone | increases expression | EXP | | 6480464 | Ozone results in increased expression of MMP9 mRNA | CTD | PMID:18007984 PMID:12763055 |
| ozone | decreases response to substance | EXP | | 6480464 | MMP9 protein results in decreased susceptibility to Ozone | CTD | PMID:18007984 |
| ozone | increases activity | EXP | | 6480464 | Ozone results in increased activity of MMP9 protein | CTD | PMID:12763055 PMID:18007984 |
| paclitaxel | multiple interactions | ISO | RGD:1348437 | 6480464 | Curcumin inhibits the reaction [Paclitaxel results in increased expression of MMP9 protein] | CTD | PMID:16243823 |
| paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of MMP9 mRNA | CTD | PMID:21135413 more ... |
| paracetamol | multiple interactions | EXP | | 6480464 | LGALS3 protein affects the reaction [Acetaminophen results in increased expression of MMP9 mRNA] | CTD | PMID:22461450 |
| paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of MMP9 mRNA | CTD | PMID:12392966 more ... |
| paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of MMP9 mRNA | CTD | PMID:12392966 more ... |
| paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of MMP9 mRNA | CTD | PMID:21135413 more ... |
| paracetamol | increases expression | ISO | RGD:621320 | 6480464 | Acetaminophen results in increased expression of MMP9 mRNA | CTD | PMID:19784758 |
| paracetamol | affects expression | ISO | RGD:621320 | 6480464 | Acetaminophen affects the expression of MMP9 mRNA | CTD | PMID:19784758 |
| paracetamol | decreases expression | ISO | RGD:621320 | 6480464 | Acetaminophen results in decreased expression of MMP9 mRNA | CTD | PMID:19784758 |
| paracetamol | multiple interactions | EXP | | 6480464 | TNFRSF1A protein affects the reaction [Acetaminophen results in increased expression of MMP9 mRNA] | CTD | PMID:14550746 |
| paracetamol | multiple interactions | EXP | | 6480464 | FLT1 protein affects the reaction [Acetaminophen results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:21135413 |
| paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of MMP9 protein | CTD | PMID:21135413 |
| paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of MMP9 mRNA | CTD | PMID:17562736 |
| paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of MMP9 mRNA | CTD | PMID:12392966 more ... |
| paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of MMP9 mRNA | CTD | PMID:14550746 more ... |
| paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of MMP9 mRNA | CTD | PMID:17215068 |
| paraquat | increases expression | ISO | RGD:621320 | 6480464 | Paraquat results in increased expression of MMP9 protein; more ... | CTD | PMID:18630695 PMID:21468558 |
| paraquat | increases expression | ISO | RGD:621320 | 6480464 | Paraquat results in increased expression of MMP9 protein; more ... | CTD | PMID:21468558 |
| paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of MMP9 protein | CTD | PMID:21765237 |
| paraquat | multiple interactions | EXP | | 6480464 | Dapsone inhibits the reaction [Paraquat results in increased expression of MMP9 protein] | CTD | PMID:21765237 |
| paraquat | increases expression | ISO | RGD:1348437 | 6480464 | Paraquat results in increased expression of MMP9 mRNA | CTD | PMID:22230393 |
| perfluorooctanoic acid | multiple interactions | ISO | RGD:1348437 | 6480464 | perfluorooctanoic acid inhibits the reaction [Lipopolysaccharides results in increased secretion of MMP9 protein]; more ... | CTD | PMID:21075133 |
| perindopril | multiple interactions | ISO | RGD:621320 | 6480464 | Perindopril inhibits the reaction [Carbon Tetrachloride results in increased activity of MMP9 protein] | CTD | PMID:16097048 |
| phenylephrine | increases expression | ISO | RGD:1348437 | 6480464 | Phenylephrine results in increased expression of MMP9 mRNA | CTD | PMID:16574429 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1348437 | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [pioglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]]; more ... | CTD | PMID:17055343 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1348437 | 6480464 | PD 98059 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]; more ... | CTD | PMID:19447859 PMID:19804834 |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:1348437 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA | CTD | PMID:10569804 more ... |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1348437 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein | CTD | PMID:18628248 more ... |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1348437 | 6480464 | Melitten inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased secretion of MMP9 protein]; more ... | CTD | PMID:20082219 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1348437 | 6480464 | Bee Venoms inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]; more ... | CTD | PMID:19969058 |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:1348437 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA | CTD | PMID:10569804 more ... |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1348437 | 6480464 | 3,4-dihydroxyphenylethanol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:22595400 |
| phorbol 13-acetate 12-myristate | increases secretion | ISO | RGD:1348437 | 6480464 | Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein | CTD | PMID:12745093 more ... |
| phorbol 13-acetate 12-myristate | multiple interactions | EXP | | 6480464 | Dexamethasone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]; more ... | CTD | PMID:14515793 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1348437 | 6480464 | Quercetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] | CTD | PMID:18628248 PMID:22595400 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1348437 | 6480464 | resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:22523472 PMID:22595400 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1348437 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]; more ... | CTD | PMID:19447859 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1348437 | 6480464 | arsenic trioxide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein] | CTD | PMID:15962302 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1348437 | 6480464 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]; more ... | CTD | PMID:20590612 |
| phorbol 13-acetate 12-myristate | increases secretion | ISO | RGD:1348437 | 6480464 | Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein | CTD | PMID:12745093 more ... |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1348437 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein | CTD | PMID:18628248 more ... |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:1348437 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA | CTD | PMID:10569804 more ... |
| phorbol 13-acetate 12-myristate | increases activity | ISO | RGD:1348437 | 6480464 | Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein | CTD | PMID:17055343 more ... |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1348437 | 6480464 | Tetradecanoylphorbol Acetate results in increased activity of and results in increased expression of MMP9 protein | CTD | PMID:14627504 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1348437 | 6480464 | oxophenylarsine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]; more ... | CTD | PMID:10569804 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1348437 | 6480464 | 4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine promotes the reaction [Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]]; more ... | CTD | PMID:20152819 |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:1348437 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein | CTD | PMID:10569804 more ... |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1348437 | 6480464 | 4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]; more ... | CTD | PMID:20152819 PMID:21354279 |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:1348437 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein | CTD | PMID:17498959 more ... |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:1348437 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA | CTD | PMID:12745093 more ... |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1348437 | 6480464 | Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] | CTD | PMID:20152819 more ... |
| phorbol 13-acetate 12-myristate | increases activity | ISO | RGD:1348437 | 6480464 | Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein | CTD | PMID:17055343 more ... |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:1348437 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA | CTD | PMID:12745093 more ... |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1348437 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein | CTD | PMID:18628248 more ... |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1348437 | 6480464 | 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein] | CTD | PMID:22245252 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1348437 | 6480464 | Apigenin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]; more ... | CTD | PMID:22634262 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1348437 | 6480464 | Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] | CTD | PMID:20599481 PMID:21354279 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1348437 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein | CTD | PMID:18628248 more ... |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1348437 | 6480464 | 4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:21354279 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1348437 | 6480464 | 3-caffeoyl-4-dihydrocaffeoylquinic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]; more ... | CTD | PMID:20599481 |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:1348437 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein | CTD | PMID:17498959 more ... |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:1348437 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA | CTD | PMID:12745093 more ... |
| phorbol 13-acetate 12-myristate | increases activity | ISO | RGD:1348437 | 6480464 | Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein | CTD | PMID:17055343 more ... |
| phorbol 13-acetate 12-myristate | increases secretion | ISO | RGD:1348437 | 6480464 | Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein | CTD | PMID:12745093 more ... |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1348437 | 6480464 | PD 98059 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]; more ... | CTD | PMID:12745093 more ... |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1348437 | 6480464 | Hesperidin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] | CTD | PMID:20138977 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1348437 | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [10-nitro-oleic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]]; more ... | CTD | PMID:21454668 |
| phorbol 13-acetate 12-myristate | increases secretion | ISO | RGD:1348437 | 6480464 | Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein | CTD | PMID:12745093 more ... |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:1348437 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA | CTD | PMID:19375915 more ... |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1348437 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein | CTD | PMID:19375915 more ... |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:1348437 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA | CTD | PMID:16574429 more ... |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1348437 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein | CTD | PMID:21295103 more ... |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1348437 | 6480464 | wogonin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein] | CTD | PMID:21295103 |
| phorbol 13-acetate 12-myristate | increases secretion | ISO | RGD:1348437 | 6480464 | Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein | CTD | PMID:20188714 more ... |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:1348437 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA | CTD | PMID:19804834 more ... |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1348437 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein | CTD | PMID:19375915 more ... |
| phorbol 13-acetate 12-myristate | increases secretion | ISO | RGD:1348437 | 6480464 | Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein | CTD | PMID:15728660 more ... |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:1348437 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein | CTD | PMID:20093109 PMID:17498959 |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:1348437 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA | CTD | PMID:15728660 more ... |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1348437 | 6480464 | PD 98059 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein] | CTD | PMID:12745093 PMID:15728660 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1348437 | 6480464 | troglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] | CTD | PMID:18155510 |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:1348437 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein | CTD | PMID:17498959 PMID:20093109 |
| phorbol 13-acetate 12-myristate | increases secretion | ISO | RGD:1348437 | 6480464 | Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein | CTD | PMID:20188714 more ... |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:1348437 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA | CTD | PMID:16574429 more ... |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1348437 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein | CTD | PMID:18628248 PMID:19375915 |
| phorbol 13-acetate 12-myristate | increases activity | ISO | RGD:1348437 | 6480464 | Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein | CTD | PMID:17055343 PMID:19804834 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1348437 | 6480464 | PD 98059 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein] | CTD | PMID:15728660 PMID:12745093 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1348437 | 6480464 | N-2-(4-bromophenyl) ethyl caffeamide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein] | CTD | PMID:20093109 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1348437 | 6480464 | glycitein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein] | CTD | PMID:20188714 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1348437 | 6480464 | Doxycycline inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]; more ... | CTD | PMID:17498959 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1348437 | 6480464 | Doxycycline inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]; more ... | CTD | PMID:19375915 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1348437 | 6480464 | atorvastatin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]; more ... | CTD | PMID:15728660 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:621320 | 6480464 | [Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased activity of MMP9 protein; more ... | CTD | PMID:14700523 |
| phorbol 13-acetate 12-myristate | increases secretion | ISO | RGD:1348437 | 6480464 | Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein | CTD | PMID:12745093 |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:1348437 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA | CTD | PMID:18628248 more ... |
| phorbol 13-acetate 12-myristate | increases activity | ISO | RGD:1348437 | 6480464 | Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein | CTD | PMID:19804834 PMID:17055343 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1348437 | 6480464 | Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]; more ... | CTD | PMID:18628248 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1348437 | 6480464 | bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]; more ... | CTD | PMID:12745093 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1348437 | 6480464 | baicalein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]; more ... | CTD | PMID:19804834 |
| phosgene | multiple interactions | ISO | RGD:621320 | 6480464 | Dexamethasone inhibits the reaction [Phosgene results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:21941784 |
| phosgene | increases expression | ISO | RGD:621320 | 6480464 | Phosgene results in increased expression of MMP9 protein; more ... | CTD | PMID:21941784 |
| pioglitazone | multiple interactions | ISO | RGD:1348437 | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [pioglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]] | CTD | PMID:17055343 |
| pioglitazone | decreases secretion | ISO | RGD:1348437 | 6480464 | pioglitazone results in decreased secretion of MMP9 protein | CTD | PMID:16860414 |
| pravastatin | decreases activity | ISO | RGD:621320 | 6480464 | Pravastatin results in decreased activity of MMP9 protein | CTD | PMID:16935385 |
| pravastatin | decreases expression | ISO | RGD:621320 | 6480464 | Pravastatin results in decreased expression of MMP9 mRNA | CTD | PMID:16935385 |
| prednisolone | multiple interactions | ISO | RGD:621320 | 6480464 | Prednisolone inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of and results in increased cleavage of MMP9 protein] | CTD | PMID:22119283 |
| pregnenolone 16alpha-carbonitrile | decreases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in decreased expression of MMP9 mRNA | CTD | PMID:22698814 |
| progesterone | multiple interactions | ISO | RGD:1348437 | 6480464 | [Progesterone co-treated with Estradiol] results in decreased expression of MMP9 mRNA | CTD | PMID:17404688 |
| propranolol | multiple interactions | ISO | RGD:1348437 | 6480464 | Propranolol inhibits the reaction [Isoproterenol results in increased expression of MMP9 mRNA] | CTD | PMID:16574429 |
| propranolol | decreases secretion | ISO | RGD:1348437 | 6480464 | Propranolol results in decreased secretion of MMP9 protein | CTD | PMID:20424515 |
| propranolol | decreases expression | ISO | RGD:1348437 | 6480464 | Propranolol results in decreased expression of MMP9 mRNA; more ... | CTD | PMID:20424515 |
| propranolol | decreases expression | ISO | RGD:1348437 | 6480464 | Propranolol results in decreased expression of MMP9 | CTD | PMID:21042766 |
| prostaglandin E2 | multiple interactions | ISO | RGD:1348437 | 6480464 | 15-deoxyprostaglandin J2 inhibits the reaction [Dinoprostone results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:19880272 |
| prostaglandin E2 | increases expression | ISO | RGD:1348437 | 6480464 | Dinoprostone results in increased expression of MMP9 mRNA | CTD | PMID:19880272 PMID:16330497 |
| prostaglandin E2 | increases secretion | ISO | RGD:1348437 | 6480464 | Dinoprostone results in increased secretion of MMP9 protein | CTD | PMID:19880272 |
| prostaglandin E2 | increases expression | ISO | RGD:1348437 | 6480464 | Dinoprostone results in increased expression of MMP9 protein | CTD | PMID:16330497 |
| prostaglandin E2 | increases expression | ISO | RGD:1348437 | 6480464 | Dinoprostone results in increased expression of MMP9 mRNA | CTD | PMID:16330497 PMID:19880272 |
| prostaglandin F2alpha | multiple interactions | ISO | RGD:1348437 | 6480464 | Dinoprost results in increased expression of and results in increased activity of MMP9 protein | CTD | PMID:11719597 |
| pterostilbene | decreases expression | ISO | RGD:1348437 | 6480464 | pterostilbene results in decreased expression of MMP9 mRNA | CTD | PMID:20152895 |
| pterostilbene | decreases activity | ISO | RGD:1348437 | 6480464 | pterostilbene results in decreased activity of MMP9 protein | CTD | PMID:19617202 |
| pterostilbene | multiple interactions | EXP | | 6480464 | pterostilbene inhibits the reaction [MMP7 protein results in increased activity of MMP9 protein] | CTD | PMID:20681671 |
| pterostilbene | multiple interactions | ISO | RGD:1348437 | 6480464 | pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]; more ... | CTD | PMID:19447859 |
| quercetin | multiple interactions | ISO | RGD:1348437 | 6480464 | Quercetin inhibits the reaction [EGF protein results in increased secretion of MMP9 protein] | CTD | PMID:15135307 |
| quercetin | multiple interactions | EXP | | 6480464 | Quercetin inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA] | CTD | PMID:19401153 |
| quercetin | multiple interactions | ISO | RGD:1348437 | 6480464 | Quercetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein] | CTD | PMID:22595400 |
| quercetin | multiple interactions | ISO | RGD:1348437 | 6480464 | Quercetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] | CTD | PMID:18628248 PMID:22595400 |
| quercetin | multiple interactions | ISO | RGD:621320 | 6480464 | Quercetin inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased activity of MMP9 protein] | CTD | PMID:14700523 |
| quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of MMP9 mRNA | CTD | PMID:16304905 |
| quercetin | multiple interactions | EXP | | 6480464 | Quercetin inhibits the reaction [TNFSF11 protein results in increased expression of MMP9 mRNA] | CTD | PMID:19495926 |
| quercetin | decreases secretion | ISO | RGD:1348437 | 6480464 | Quercetin results in decreased secretion of MMP9 protein | CTD | PMID:15135307 |
| quercetin | multiple interactions | ISO | RGD:1348437 | 6480464 | Quercetin inhibits the reaction [TNF protein results in increased activity of MMP9 protein]; more ... | CTD | PMID:12589822 |
| quercetin | multiple interactions | ISO | RGD:1348437 | 6480464 | Quercetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]; more ... | CTD | PMID:18628248 |
| quercetin | multiple interactions | ISO | RGD:1348437 | 6480464 | Quercetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] | CTD | PMID:19804834 |
| quercetin 3-O-beta-D-glucoside | multiple interactions | ISO | RGD:1348437 | 6480464 | isoquercitrin results in decreased expression of and results in decreased activity of MMP9 protein | CTD | PMID:18715546 |
| raloxifene | decreases expression | ISO | RGD:1348437 | 6480464 | Raloxifene results in decreased expression of MMP9 mRNA | CTD | PMID:17582780 |
| raloxifene | increases expression | EXP | | 6480464 | Raloxifene results in increased expression of MMP9 mRNA | CTD | PMID:22841776 |
| raloxifene | decreases activity | ISO | RGD:1348437 | 6480464 | Raloxifene results in decreased activity of MMP9 protein | CTD | PMID:17582780 |
| ranitidine | multiple interactions | ISO | RGD:621320 | 6480464 | Ranitidine inhibits the reaction [Ethanol results in increased secretion of and results in increased activity of MMP9 protein] | CTD | PMID:17603938 |
| razoxane | multiple interactions | ISO | RGD:621320 | 6480464 | Razoxane inhibits the reaction [Doxorubicin results in increased expression of MMP9 mRNA] | CTD | PMID:16213474 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [TNF protein results in increased expression of MMP9 protein]; more ... | CTD | PMID:22069489 |
| resveratrol | decreases expression | ISO | RGD:621320 | 6480464 | resveratrol results in decreased expression of MMP9 mRNA | CTD | PMID:19228061 PMID:22552115 |
| resveratrol | decreases expression | ISO | RGD:621320 | 6480464 | resveratrol results in decreased expression of MMP9 mRNA | CTD | PMID:19228061 |
| resveratrol | multiple interactions | ISO | RGD:1348437 | 6480464 | [resveratrol results in decreased expression of [RELA co-treated with FOS]] which results in decreased expression of MMP9; more ... | CTD | PMID:21238464 |
| resveratrol | decreases expression | ISO | RGD:1348437 | 6480464 | resveratrol results in decreased expression of MMP9 protein | CTD | PMID:16490592 more ... |
| resveratrol | decreases expression | ISO | RGD:1348437 | 6480464 | resveratrol results in decreased expression of MMP9 mRNA | CTD | PMID:14627504 more ... |
| resveratrol | multiple interactions | ISO | RGD:1348437 | 6480464 | resveratrol results in decreased expression of and results in decreased activity of MMP9 protein | CTD | PMID:14627504 PMID:17049120 |
| resveratrol | decreases expression | ISO | RGD:1348437 | 6480464 | resveratrol results in decreased expression of MMP9 | CTD | PMID:21238464 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Calcium Chloride results in increased activity of MMP9 protein] | CTD | PMID:21530968 |
| resveratrol | decreases secretion | ISO | RGD:1348437 | 6480464 | resveratrol results in decreased secretion of MMP9 protein | CTD | PMID:18674879 |
| resveratrol | decreases expression | ISO | RGD:1348437 | 6480464 | resveratrol results in decreased expression of MMP9 mRNA | CTD | PMID:14627504 more ... |
| resveratrol | multiple interactions | ISO | RGD:1348437 | 6480464 | resveratrol results in decreased expression of and results in decreased activity of MMP9 protein | CTD | PMID:14627504 more ... |
| resveratrol | multiple interactions | ISO | RGD:1348437 | 6480464 | resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:22523472 PMID:22595400 |
| resveratrol | multiple interactions | ISO | RGD:1348437 | 6480464 | resveratrol inhibits the reaction [2,2'-Dipyridyl results in increased activity of MMP9 protein]; more ... | CTD | PMID:18674879 |
| resveratrol | affects expression | ISO | RGD:1348437 | 6480464 | resveratrol affects the expression of MMP9 protein | CTD | PMID:17007354 |
| resveratrol | multiple interactions | ISO | RGD:1348437 | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [resveratrol affects the expression of MMP9 protein] | CTD | PMID:17007354 |
| resveratrol | decreases activity | ISO | RGD:1348437 | 6480464 | resveratrol results in decreased activity of MMP9 protein | CTD | PMID:17935668 PMID:15688415 |
| resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of MMP9 mRNA | CTD | PMID:16321402 PMID:16304905 |
| resveratrol | multiple interactions | ISO | RGD:1348437 | 6480464 | resveratrol inhibits the reaction [HMOX1 protein results in increased expression of MMP9 protein] | CTD | PMID:20461740 |
| resveratrol | decreases expression | ISO | RGD:1348437 | 6480464 | resveratrol results in decreased expression of MMP9 mRNA | CTD | PMID:17935668 |
| resveratrol | multiple interactions | ISO | RGD:1348437 | 6480464 | resveratrol results in decreased expression of and results in decreased activity of MMP9 protein | CTD | PMID:17049120 |
| resveratrol | multiple interactions | ISO | RGD:1348437 | 6480464 | resveratrol inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:16317118 |
| resveratrol | decreases activity | ISO | RGD:1348437 | 6480464 | resveratrol results in decreased activity of MMP9 protein | CTD | PMID:15688415 PMID:17935668 |
| resveratrol | multiple interactions | ISO | RGD:1348437 | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]] | CTD | PMID:17055343 |
| resveratrol | multiple interactions | ISO | RGD:1348437 | 6480464 | resveratrol inhibits the reaction [NRG1 protein alternative form results in increased expression of MMP9 protein] | CTD | PMID:17651959 |
| resveratrol | multiple interactions | ISO | RGD:1348437 | 6480464 | resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of MMP9 protein]; more ... | CTD | PMID:19371443 |
| resveratrol | multiple interactions | ISO | RGD:621320 | 6480464 | resveratrol affects the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of MMP9 mRNA] | CTD | PMID:15734790 |
| resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of MMP9 mRNA | CTD | PMID:16304905 PMID:16321402 |
| resveratrol | decreases expression | ISO | RGD:1348437 | 6480464 | resveratrol results in decreased expression of MMP9 protein | CTD | PMID:16490592 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol results in decreased expression of and results in decreased activity of MMP9 protein | CTD | PMID:16321402 |
| resveratrol | increases secretion | ISO | RGD:1348437 | 6480464 | resveratrol results in increased secretion of MMP9 protein | CTD | PMID:22314268 |
| resveratrol | multiple interactions | ISO | RGD:1348437 | 6480464 | [SU 1498 results in decreased activity of KDR protein] inhibits the reaction [resveratrol results in increased secretion of MMP9 protein] | CTD | PMID:22314268 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Croton Oil results in increased expression of MMP9 protein]; more ... | CTD | PMID:14515793 |
| resveratrol | decreases activity | ISO | RGD:621320 | 6480464 | resveratrol results in decreased activity of MMP9 protein | CTD | PMID:21962734 |
| resveratrol | multiple interactions | ISO | RGD:621320 | 6480464 | resveratrol inhibits the reaction [Streptozocin results in increased expression of MMP9 mRNA] | CTD | PMID:22191573 |
| resveratrol | multiple interactions | ISO | RGD:621320 | 6480464 | resveratrol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MMP9 protein] | CTD | PMID:12208745 |
| riboflavin | increases activity | EXP | | 6480464 | Riboflavin analog results in increased activity of MMP9 protein; more ... | CTD | PMID:20688149 |
| rosiglitazone | decreases expression | ISO | RGD:1348437 | 6480464 | rosiglitazone results in decreased expression of MMP9 mRNA | CTD | PMID:20021931 |
| rosiglitazone | multiple interactions | ISO | RGD:1348437 | 6480464 | rosiglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:21454668 |
| rosiglitazone | multiple interactions | ISO | RGD:621320 | 6480464 | rosiglitazone inhibits the reaction [Streptozocin deficiency results in increased expression of MMP9 mRNA] | CTD | PMID:19236438 |
| rosiglitazone | decreases secretion | ISO | RGD:1348437 | 6480464 | rosiglitazone results in decreased secretion of MMP9 protein | CTD | PMID:20021931 |
| rosiglitazone | decreases activity | ISO | RGD:621320 | 6480464 | rosiglitazone results in decreased activity of MMP9 protein | CTD | PMID:19201691 |
| rotenone | multiple interactions | EXP | | 6480464 | Rotenone inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA] | CTD | PMID:15557194 |
| roxarsone | increases expression | ISO | RGD:1348437 | 6480464 | Roxarsone results in increased expression of MMP9 mRNA; more ... | CTD | PMID:22952646 |
| rutin | decreases expression | EXP | | 6480464 | Rutin results in decreased expression of MMP9 mRNA | CTD | PMID:16304905 |
| sanguinarine | decreases expression | ISO | RGD:1348437 | 6480464 | sanguinarine results in decreased expression of MMP9 mRNA; more ... | CTD | PMID:19063874 |
| selenium atom | decreases expression | ISO | RGD:1348437 | 6480464 | Selenium results in decreased expression of MMP9 mRNA | CTD | PMID:17390030 |
| silicon dioxide | increases expression | ISO | RGD:621320 | 6480464 | Silicon Dioxide results in increased expression of MMP9 mRNA | CTD | PMID:21602193 |
| silicon dioxide | increases expression | ISO | RGD:1348437 | 6480464 | Silicon Dioxide results in increased expression of MMP9 mRNA | CTD | PMID:22931364 |
| silicon dioxide | multiple interactions | ISO | RGD:1348437 | 6480464 | fisetin inhibits the reaction [Silicon Dioxide results in increased expression of MMP9 mRNA] | CTD | PMID:22931364 |
| simazine | decreases expression | EXP | | 6480464 | Simazine results in decreased expression of MMP9 mRNA | CTD | PMID:22984576 |
| simvastatin | multiple interactions | ISO | RGD:1348437 | 6480464 | Simvastatin inhibits the reaction [TNF protein results in increased expression of MMP9 protein] | CTD | PMID:17277159 |
| simvastatin | decreases expression | ISO | RGD:621320 | 6480464 | Simvastatin results in decreased expression of MMP9 mRNA | CTD | PMID:16414398 PMID:18309148 |
| simvastatin | decreases expression | ISO | RGD:1348437 | 6480464 | Simvastatin results in decreased expression of MMP9 protein | CTD | PMID:17038636 more ... |
| simvastatin | decreases expression | ISO | RGD:1348437 | 6480464 | Simvastatin results in decreased expression of MMP9 protein | CTD | PMID:19360310 more ... |
| simvastatin | decreases expression | ISO | RGD:1348437 | 6480464 | Simvastatin results in decreased expression of MMP9 protein | CTD | PMID:19589242 more ... |
| simvastatin | multiple interactions | ISO | RGD:1348437 | 6480464 | Simvastatin inhibits the reaction [TNF results in increased secretion of MMP9 protein] | CTD | PMID:17560598 PMID:15537504 |
| simvastatin | multiple interactions | ISO | RGD:1348437 | 6480464 | Simvastatin inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 protein] | CTD | PMID:17038636 |
| simvastatin | multiple interactions | ISO | RGD:1348437 | 6480464 | Simvastatin inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA] | CTD | PMID:18625914 |
| simvastatin | multiple interactions | ISO | RGD:1348437 | 6480464 | geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [[IL1A co-treated with PDGFB] results in increased secretion of MMP9 protein]]; more ... | CTD | PMID:15728660 |
| simvastatin | decreases expression | ISO | RGD:621320 | 6480464 | Simvastatin results in decreased expression of MMP9 protein | CTD | PMID:16414398 |
| simvastatin | decreases expression | ISO | RGD:621320 | 6480464 | Simvastatin results in decreased expression of MMP9 mRNA | CTD | PMID:18309148 PMID:16414398 |
| simvastatin | multiple interactions | ISO | RGD:621320 | 6480464 | Simvastatin results in decreased expression of and results in decreased activity of MMP9 protein | CTD | PMID:18309148 |
| simvastatin | multiple interactions | ISO | RGD:621320 | 6480464 | Simvastatin inhibits the reaction [Streptozocin results in increased expression of MMP9 mRNA] | CTD | PMID:19820293 |
| simvastatin | decreases activity | ISO | RGD:621320 | 6480464 | Simvastatin results in decreased activity of MMP9 protein | CTD | PMID:18569431 |
| simvastatin | multiple interactions | ISO | RGD:621320 | 6480464 | Simvastatin inhibits the reaction [Smoke analog results in increased activity of MMP9 protein] | CTD | PMID:16002570 |
| simvastatin | multiple interactions | ISO | RGD:621320 | 6480464 | Simvastatin inhibits the reaction [Cholesterol, Dietary results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:19505368 |
| simvastatin | decreases activity | EXP | | 6480464 | Simvastatin results in decreased activity of MMP9 protein | CTD | PMID:17169357 |
| simvastatin | multiple interactions | ISO | RGD:621320 | 6480464 | farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Smoke analog results in increased expression of MMP9 mRNA]]; more ... | CTD | PMID:19299917 |
| simvastatin | multiple interactions | EXP | | 6480464 | Simvastatin inhibits the reaction [[Dietary Fats co-treated with Cholesterol, Dietary] results in increased expression of MMP9 protein]; more ... | CTD | PMID:20835264 |
| simvastatin | decreases activity | ISO | RGD:1348437 | 6480464 | Simvastatin results in decreased activity of MMP9 protein | CTD | PMID:15107580 |
| simvastatin | increases activity | ISO | RGD:1348437 | 6480464 | Simvastatin results in increased activity of MMP9 protein | CTD | PMID:15210533 |
| simvastatin | multiple interactions | ISO | RGD:1348437 | 6480464 | Simvastatin inhibits the reaction [TNF results in increased secretion of MMP9 protein] | CTD | PMID:15537504 PMID:17560598 |
| simvastatin | decreases expression | ISO | RGD:1348437 | 6480464 | Simvastatin results in decreased expression of MMP9 protein | CTD | PMID:19360310 more ... |
| simvastatin | multiple interactions | ISO | RGD:1348437 | 6480464 | Simvastatin promotes the reaction [TNF results in increased expression of MMP9 mRNA] | CTD | PMID:17560598 |
| sirolimus | decreases expression | ISO | RGD:621320 | 6480464 | Sirolimus results in decreased expression of MMP9 mRNA | CTD | PMID:21865292 |
| staurosporine | multiple interactions | ISO | RGD:1348437 | 6480464 | Staurosporine inhibits the reaction [Homocysteine results in increased activity of MMP9 protein]; more ... | CTD | PMID:16251475 |
| streptozocin | multiple interactions | ISO | RGD:1348437 | 6480464 | PRDX4 protein inhibits the reaction [Streptozocin results in increased expression of MMP9 mRNA] | CTD | PMID:20446767 |
| streptozocin | multiple interactions | ISO | RGD:621320 | 6480464 | resveratrol inhibits the reaction [Streptozocin results in increased expression of MMP9 mRNA] | CTD | PMID:22191573 |
| streptozocin | increases activity | EXP | | 6480464 | Streptozocin results in increased activity of MMP9 protein | CTD | PMID:22543014 |
| streptozocin | multiple interactions | EXP | | 6480464 | pimagedine inhibits the reaction [Streptozocin results in increased activity of MMP9 protein] | CTD | PMID:22543014 |
| streptozocin | increases expression | ISO | RGD:621320 | 6480464 | Streptozocin results in increased expression of MMP9 mRNA | CTD | PMID:19236438 more ... |
| streptozocin | increases expression | ISO | RGD:621320 | 6480464 | Streptozocin results in increased expression of MMP9 mRNA | CTD | PMID:19236438 PMID:19820293 |
| streptozocin | increases expression | ISO | RGD:621320 | 6480464 | Streptozocin results in increased expression of MMP9 mRNA | CTD | PMID:19820293 PMID:19236438 |
| streptozocin | multiple interactions | ISO | RGD:621320 | 6480464 | Simvastatin inhibits the reaction [Streptozocin results in increased expression of MMP9 mRNA] | CTD | PMID:19820293 |
| streptozocin | multiple interactions | ISO | RGD:621320 | 6480464 | rosiglitazone inhibits the reaction [Streptozocin deficiency results in increased expression of MMP9 mRNA] | CTD | PMID:19236438 |
| streptozocin | increases expression | EXP | | 6480464 | Streptozocin results in increased expression of MMP9 mRNA | CTD | PMID:20446767 |
| succimer | multiple interactions | EXP | | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of MMP9 mRNA | CTD | PMID:21641980 |
| sulfasalazine | multiple interactions | ISO | RGD:1348437 | 6480464 | Sulfasalazine inhibits the reaction [HGF protein results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:12745093 |
| sulfasalazine | multiple interactions | ISO | RGD:621320 | 6480464 | Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of and results in increased cleavage of MMP9 protein] | CTD | PMID:22119283 |
| tamoxifen | affects expression | ISO | RGD:1348437 | 6480464 | Tamoxifen affects the expression of MMP9 mRNA | CTD | PMID:14699072 |
| tamoxifen | increases expression | EXP | | 6480464 | Tamoxifen results in increased expression of MMP9 mRNA | CTD | PMID:22841776 |
| tamoxifen | increases activity | EXP | | 6480464 | Tamoxifen results in increased activity of MMP9 protein | CTD | PMID:19279558 |
| tamoxifen | decreases activity | EXP | | 6480464 | Tamoxifen results in decreased activity of MMP9 protein | CTD | PMID:19393235 |
| tamoxifen | decreases activity | ISO | RGD:621320 | 6480464 | Tamoxifen results in decreased activity of MMP9 protein | CTD | PMID:15696052 |
| tamoxifen | decreases expression | EXP | | 6480464 | Tamoxifen results in decreased expression of MMP9 mRNA | CTD | PMID:19393235 |
| tamoxifen | affects expression | EXP | | 6480464 | Tamoxifen affects the expression of MMP9 mRNA | CTD | PMID:17555576 |
| tephrosin | multiple interactions | ISO | RGD:1348437 | 6480464 | tephrosin inhibits the reaction [TNF protein results in increased expression of MMP9 protein] | CTD | PMID:18841906 |
| tetrachloromethane | decreases expression | ISO | RGD:621320 | 6480464 | Carbon Tetrachloride results in decreased expression of MMP9 mRNA | CTD | PMID:19784758 PMID:17056239 |
| tetrachloromethane | multiple interactions | EXP | | 6480464 | Luteolin inhibits the reaction [Carbon Tetrachloride results in decreased expression of MMP9 protein] | CTD | PMID:19747501 |
| tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of MMP9 protein | CTD | PMID:19747501 |
| tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of MMP9 protein | CTD | PMID:20371262 PMID:17944888 |
| tetrachloromethane | increases expression | ISO | RGD:621320 | 6480464 | Carbon Tetrachloride results in increased expression of MMP9 mRNA | CTD | PMID:16420518 more ... |
| tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of MMP9 protein | CTD | PMID:17944888 PMID:20371262 |
| tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of MMP9 mRNA | CTD | PMID:15056808 PMID:20438794 |
| tetrachloromethane | increases expression | ISO | RGD:621320 | 6480464 | Carbon Tetrachloride results in increased expression of MMP9 mRNA | CTD | PMID:17631135 more ... |
| tetrachloromethane | increases expression | ISO | RGD:621320 | 6480464 | Carbon Tetrachloride results in increased expression of MMP9 mRNA | CTD | PMID:16420518 more ... |
| tetrachloromethane | multiple interactions | EXP | | 6480464 | delphinidin promotes the reaction [Carbon Tetrachloride results in increased expression of MMP9 protein] | CTD | PMID:20371262 |
| tetrachloromethane | multiple interactions | ISO | RGD:621320 | 6480464 | Perindopril inhibits the reaction [Carbon Tetrachloride results in increased activity of MMP9 protein] | CTD | PMID:16097048 |
| tetrachloromethane | multiple interactions | ISO | RGD:621320 | 6480464 | PLAU protein promotes the reaction [Carbon Tetrachloride results in increased expression of MMP9 mRNA] | CTD | PMID:18481824 |
| tetrachloromethane | multiple interactions | ISO | RGD:621320 | 6480464 | celecoxib promotes the reaction [Carbon Tetrachloride results in increased expression of MMP9 mRNA] | CTD | PMID:16420518 |
| tetrachloromethane | increases expression | ISO | RGD:621320 | 6480464 | Carbon Tetrachloride results in increased expression of MMP9 protein | CTD | PMID:17631135 |
| tetrachloromethane | increases activity | ISO | RGD:621320 | 6480464 | Carbon Tetrachloride results in increased activity of MMP9 protein | CTD | PMID:16097048 |
| tetrachloromethane | increases expression | ISO | RGD:621320 | 6480464 | Carbon Tetrachloride results in increased expression of MMP9 mRNA | CTD | PMID:18481824 more ... |
| tetrachloromethane | decreases expression | ISO | RGD:621320 | 6480464 | Carbon Tetrachloride results in decreased expression of MMP9 protein | CTD | PMID:17156884 |
| tetrachloromethane | decreases expression | ISO | RGD:621320 | 6480464 | Carbon Tetrachloride results in decreased expression of MMP9 mRNA | CTD | PMID:17056239 PMID:19784758 |
| tetrachloromethane | decreases activity | ISO | RGD:621320 | 6480464 | Carbon Tetrachloride results in decreased activity of MMP9 protein | CTD | PMID:17156884 |
| tetrachloromethane | multiple interactions | ISO | RGD:621320 | 6480464 | [Carbon Tetrachloride co-treated with Interleukin 1 Receptor Antagonist Protein] results in increased expression of MMP9 mRNA | CTD | PMID:16762003 |
| tetrachloromethane | multiple interactions | EXP | | 6480464 | PPARD protein affects the reaction [Carbon Tetrachloride results in increased expression of MMP9 mRNA] | CTD | PMID:18038451 |
| tetrachloromethane | multiple interactions | EXP | | 6480464 | PLAT protein affects the reaction [Carbon Tetrachloride results in increased expression of MMP9 protein] | CTD | PMID:17944888 |
| tetrachloromethane | multiple interactions | EXP | | 6480464 | OSMR protein affects the reaction [Carbon Tetrachloride results in increased activity of MMP9 protein] | CTD | PMID:14999682 |
| tetrachloromethane | multiple interactions | EXP | | 6480464 | MMP9 protein inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein]; more ... | CTD | PMID:16507762 |
| tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of MMP9 protein | CTD | PMID:17944888 |
| tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of MMP9 mRNA | CTD | PMID:15056808 |
| tetrachloromethane | increases activity | EXP | | 6480464 | Carbon Tetrachloride results in increased activity of MMP9 protein | CTD | PMID:14999682 |
| tetrachloromethane | increases expression | ISO | RGD:621320 | 6480464 | Carbon Tetrachloride results in increased expression of MMP9 mRNA | CTD | PMID:18481824 more ... |
| thalidomide | decreases expression | ISO | RGD:1348437 | 6480464 | Thalidomide results in decreased expression of MMP9 protein | CTD | PMID:15863203 |
| thioacetamide | decreases expression | ISO | RGD:621320 | 6480464 | Thioacetamide results in decreased expression of MMP9 mRNA | CTD | PMID:19784758 |
| thioacetamide | increases expression | ISO | RGD:621320 | 6480464 | Thioacetamide results in increased expression of MMP9 protein | CTD | PMID:15095483 |
| titanium atom | increases expression | ISO | RGD:1348437 | 6480464 | Titanium results in increased expression of MMP9 mRNA | CTD | PMID:14661256 |
| titanium dioxide | increases expression | ISO | RGD:1348437 | 6480464 | titanium dioxide results in increased expression of MMP9 mRNA | CTD | PMID:19695317 |
| toluene 2,4-diisocyanate | multiple interactions | EXP | | 6480464 | epigallocatechin gallate inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of and results in increased activity of MMP9 protein]; more ... | CTD | PMID:16516891 |
| toluene 2,4-diisocyanate | increases expression | EXP | | 6480464 | Toluene 2,4-Diisocyanate results in increased expression of MMP9 protein | CTD | PMID:12789230 more ... |
| toluene 2,4-diisocyanate | increases expression | EXP | | 6480464 | Toluene 2,4-Diisocyanate results in increased expression of MMP9 mRNA | CTD | PMID:16516891 more ... |
| toluene 2,4-diisocyanate | increases expression | EXP | | 6480464 | Toluene 2,4-Diisocyanate results in increased expression of MMP9 protein | CTD | PMID:12789230 more ... |
| toluene 2,4-diisocyanate | increases expression | EXP | | 6480464 | Toluene 2,4-Diisocyanate results in increased expression of MMP9 protein | CTD | PMID:15131573 more ... |
| toluene 2,4-diisocyanate | increases expression | EXP | | 6480464 | Toluene 2,4-Diisocyanate results in increased expression of MMP9 mRNA | CTD | PMID:12789230 more ... |
| toluene 2,4-diisocyanate | increases expression | EXP | | 6480464 | Toluene 2,4-Diisocyanate results in increased expression of MMP9 mRNA | CTD | PMID:16516891 more ... |
| toluene 2,4-diisocyanate | increases expression | EXP | | 6480464 | Toluene 2,4-Diisocyanate results in increased expression of MMP9 mRNA | CTD | PMID:16516891 more ... |
| toluene 2,4-diisocyanate | increases expression | EXP | | 6480464 | Toluene 2,4-Diisocyanate results in increased expression of MMP9 protein | CTD | PMID:14987308 more ... |
| toluene 2,4-diisocyanate | multiple interactions | EXP | | 6480464 | 4-aminobenzoyl-glycyl-prolyl-leucyl-alanine hydroxamic acid inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:15131573 |
| toluene 2,4-diisocyanate | decreases expression | ISO | RGD:1348437 | 6480464 | Toluene 2,4-Diisocyanate results in decreased expression of MMP9 protein | CTD | PMID:12534559 |
| toluene 2,4-diisocyanate | increases expression | EXP | | 6480464 | Toluene 2,4-Diisocyanate results in increased expression of MMP9 protein | CTD | PMID:15131573 more ... |
| toluene 2,4-diisocyanate | increases expression | EXP | | 6480464 | Toluene 2,4-Diisocyanate results in increased expression of MMP9 mRNA | CTD | PMID:15131573 more ... |
| toluene 2,4-diisocyanate | increases activity | EXP | | 6480464 | Toluene 2,4-Diisocyanate results in increased activity of MMP9 protein | CTD | PMID:11742282 |
| trans-resveratrol | multiple interactions | ISO | RGD:621320 | 6480464 | resveratrol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MMP9 protein] | CTD | PMID:12208745 |
| trans-resveratrol | decreases expression | ISO | RGD:621320 | 6480464 | resveratrol results in decreased expression of MMP9 mRNA | CTD | PMID:19228061 PMID:22552115 |
| trans-resveratrol | decreases expression | ISO | RGD:621320 | 6480464 | resveratrol results in decreased expression of MMP9 mRNA | CTD | PMID:19228061 |
| trans-resveratrol | multiple interactions | ISO | RGD:1348437 | 6480464 | [resveratrol results in decreased expression of [RELA co-treated with FOS]] which results in decreased expression of MMP9; more ... | CTD | PMID:21238464 |
| trans-resveratrol | decreases expression | ISO | RGD:1348437 | 6480464 | resveratrol results in decreased expression of MMP9 protein | CTD | PMID:16490592 more ... |
| trans-resveratrol | decreases expression | ISO | RGD:1348437 | 6480464 | resveratrol results in decreased expression of MMP9 mRNA | CTD | PMID:14627504 more ... |
| trans-resveratrol | multiple interactions | ISO | RGD:1348437 | 6480464 | resveratrol results in decreased expression of and results in decreased activity of MMP9 protein | CTD | PMID:14627504 PMID:17049120 |
| trans-resveratrol | decreases expression | ISO | RGD:1348437 | 6480464 | resveratrol results in decreased expression of MMP9 | CTD | PMID:21238464 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Calcium Chloride results in increased activity of MMP9 protein] | CTD | PMID:21530968 |
| trans-resveratrol | decreases secretion | ISO | RGD:1348437 | 6480464 | resveratrol results in decreased secretion of MMP9 protein | CTD | PMID:18674879 |
| trans-resveratrol | decreases expression | ISO | RGD:1348437 | 6480464 | resveratrol results in decreased expression of MMP9 mRNA | CTD | PMID:14627504 more ... |
| trans-resveratrol | multiple interactions | ISO | RGD:1348437 | 6480464 | resveratrol results in decreased expression of and results in decreased activity of MMP9 protein | CTD | PMID:14627504 more ... |
| trans-resveratrol | multiple interactions | ISO | RGD:1348437 | 6480464 | resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:22523472 PMID:22595400 |
| trans-resveratrol | multiple interactions | ISO | RGD:1348437 | 6480464 | resveratrol inhibits the reaction [2,2'-Dipyridyl results in increased activity of MMP9 protein]; more ... | CTD | PMID:18674879 |
| trans-resveratrol | affects expression | ISO | RGD:1348437 | 6480464 | resveratrol affects the expression of MMP9 protein | CTD | PMID:17007354 |
| trans-resveratrol | multiple interactions | ISO | RGD:1348437 | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [resveratrol affects the expression of MMP9 protein] | CTD | PMID:17007354 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [TNF protein results in increased expression of MMP9 protein]; more ... | CTD | PMID:22069489 |
| trans-resveratrol | decreases activity | ISO | RGD:1348437 | 6480464 | resveratrol results in decreased activity of MMP9 protein | CTD | PMID:17935668 PMID:15688415 |
| trans-resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of MMP9 mRNA | CTD | PMID:16321402 PMID:16304905 |
| trans-resveratrol | multiple interactions | ISO | RGD:1348437 | 6480464 | resveratrol inhibits the reaction [HMOX1 protein results in increased expression of MMP9 protein] | CTD | PMID:20461740 |
| trans-resveratrol | decreases expression | ISO | RGD:1348437 | 6480464 | resveratrol results in decreased expression of MMP9 mRNA | CTD | PMID:17935668 |
| trans-resveratrol | multiple interactions | ISO | RGD:1348437 | 6480464 | resveratrol results in decreased expression of and results in decreased activity of MMP9 protein | CTD | PMID:17049120 |
| trans-resveratrol | multiple interactions | ISO | RGD:1348437 | 6480464 | resveratrol inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:16317118 |
| trans-resveratrol | decreases activity | ISO | RGD:1348437 | 6480464 | resveratrol results in decreased activity of MMP9 protein | CTD | PMID:15688415 PMID:17935668 |
| trans-resveratrol | multiple interactions | ISO | RGD:1348437 | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]] | CTD | PMID:17055343 |
| trans-resveratrol | multiple interactions | ISO | RGD:1348437 | 6480464 | resveratrol inhibits the reaction [NRG1 protein alternative form results in increased expression of MMP9 protein] | CTD | PMID:17651959 |
| trans-resveratrol | multiple interactions | ISO | RGD:1348437 | 6480464 | resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of MMP9 protein]; more ... | CTD | PMID:19371443 |
| trans-resveratrol | multiple interactions | ISO | RGD:621320 | 6480464 | resveratrol affects the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of MMP9 mRNA] | CTD | PMID:15734790 |
| trans-resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of MMP9 mRNA | CTD | PMID:16304905 PMID:16321402 |
| trans-resveratrol | decreases expression | ISO | RGD:1348437 | 6480464 | resveratrol results in decreased expression of MMP9 protein | CTD | PMID:16490592 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol results in decreased expression of and results in decreased activity of MMP9 protein | CTD | PMID:16321402 |
| trans-resveratrol | increases secretion | ISO | RGD:1348437 | 6480464 | resveratrol results in increased secretion of MMP9 protein | CTD | PMID:22314268 |
| trans-resveratrol | multiple interactions | ISO | RGD:1348437 | 6480464 | [SU 1498 results in decreased activity of KDR protein] inhibits the reaction [resveratrol results in increased secretion of MMP9 protein] | CTD | PMID:22314268 |
| trans-resveratrol | decreases activity | ISO | RGD:621320 | 6480464 | resveratrol results in decreased activity of MMP9 protein | CTD | PMID:21962734 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Croton Oil results in increased expression of MMP9 protein]; more ... | CTD | PMID:14515793 |
| trans-resveratrol | multiple interactions | ISO | RGD:621320 | 6480464 | resveratrol inhibits the reaction [Streptozocin results in increased expression of MMP9 mRNA] | CTD | PMID:22191573 |
| tributylstannane | multiple interactions | EXP | | 6480464 | tributyltin promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of MMP9 mRNA] | CTD | PMID:22749964 |
| troglitazone | multiple interactions | ISO | RGD:1348437 | 6480464 | troglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] | CTD | PMID:18155510 |
| troglitazone | decreases activity | ISO | RGD:1348437 | 6480464 | troglitazone results in decreased activity of MMP9 protein | CTD | PMID:18155510 |
| urethane | multiple interactions | EXP | | 6480464 | [Urethane co-treated with Freund's Adjuvant] results in decreased expression of MMP9 mRNA | CTD | PMID:12400877 |
| urethane | decreases expression | EXP | | 6480464 | Urethane results in decreased expression of MMP9 mRNA | CTD | PMID:12400877 |
| ursolic acid | decreases expression | ISO | RGD:1348437 | 6480464 | ursolic acid results in decreased expression of MMP9 mRNA | CTD | PMID:21539908 |
| valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of MMP9 mRNA | CTD | PMID:17963808 |
| wogonin | multiple interactions | ISO | RGD:621320 | 6480464 | wogonin inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased activity of MMP9 protein] | CTD | PMID:14700523 |
| wogonin | multiple interactions | ISO | RGD:1348437 | 6480464 | wogonin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]; more ... | CTD | PMID:21295103 |
| wortmannin | multiple interactions | ISO | RGD:621320 | 6480464 | wortmannin inhibits the reaction [Adenosine Triphosphate results in increased activity of MMP9 protein] | CTD | PMID:20195827 |
| wortmannin | decreases activity | ISO | RGD:1348437 | 6480464 | wortmannin results in decreased activity of MMP9 protein | CTD | PMID:22033475 |
| wortmannin | multiple interactions | ISO | RGD:1348437 | 6480464 | wortmannin promotes the reaction [ovatodiolide results in decreased activity of MMP9 protein] | CTD | PMID:22033475 |
| zerumbone | decreases expression | ISO | RGD:1348437 | 6480464 | zerumbone results in decreased expression of MMP9 mRNA | CTD | PMID:16007145 |
| zidovudine | multiple interactions | ISO | RGD:621320 | 6480464 | Zidovudine inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA]; more ... | CTD | PMID:14662518 |
| zinc atom | affects binding | ISO | RGD:1348437 | 6480464 | Zinc binds to MMP9 protein | CTD | PMID:17137715 |
| zinc atom | decreases expression | ISO | RGD:1348437 | 6480464 | Zinc results in decreased expression of MMP9 mRNA | CTD | PMID:18316168 |
| zinc atom | multiple interactions | ISO | RGD:1348437 | 6480464 | Zinc inhibits the reaction [TNF protein results in increased secretion of MMP9 protein] | CTD | PMID:16606632 |
| zinc sulfate | multiple interactions | ISO | RGD:1348437 | 6480464 | Zinc Sulfate inhibits the reaction [TNF protein results in increased secretion of MMP9 protein] | CTD | PMID:16606632 |
| zinc(0) | affects binding | ISO | RGD:1348437 | 6480464 | Zinc binds to MMP9 protein | CTD | PMID:17137715 |
| zinc(0) | decreases expression | ISO | RGD:1348437 | 6480464 | Zinc results in decreased expression of MMP9 mRNA | CTD | PMID:18316168 |
| zinc(0) | multiple interactions | ISO | RGD:1348437 | 6480464 | Zinc inhibits the reaction [TNF protein results in increased secretion of MMP9 protein] | CTD | PMID:16606632 |
| zoledronic acid | multiple interactions | EXP | | 6480464 | zoledronic acid results in decreased expression of and results in decreased activity of MMP9 protein | CTD | PMID:15343380 |